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Effects of a Psychiatric Intensive care Unit in an Acute Psychiatric 
Ward. 
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Definitions. 
 
Seclusion: Placement and retention of an inpatient in a bare room in order to 
contain a clinical situation that may result in a state of emergency. 
Physical restraints: Staff restricts and holds the patient manually. 
Mechanical restraints: Use of belts, handcuffs etc which restrict the patient’s 
movements or totally prevent the patient from moving. 
Chemical restraints: The use of medication to control agitated states. 
 
 
 
 
 
Abbreviations 
 
PICU:         Psychiatric Intensive Care Unit 
 
PANSS:      The Positive And Negative Syndrome Scale for Schizophrenia 
 
S-GAF:       The Global Assessment Scale Split version 
 
BVC:           The Broset Violence Checklist  
 
SOAS-R:     The Staff Observation Aggression Scale-Revised 
 
CPT:          The European Committee for the Prevention of Torture and  
                   Inhuman or Degrading Treatment of Punishment 
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Summary 
The psychiatric acute departments are intensive units serving patients with a 
broad spectrum of psychiatric conditions. Patients with the most florid 
psychiatric symptoms are admitted to Psychiatric Intensive Care Units 
(PICUs). These units are supposed to provide the necessary diagnostic and 
acute therapeutic help, control inappropriate behaviours, and provide the 
services in an environment which assists the patients’ recovery and is 
acceptable to patients, health workers and the general society.  
PICUs are criticised for poor environments, high levels of coercion and lack of 
evidence base from controlled trials or post occupancy evaluations. Long term 
studies of the rate of seclusion indicate no decrease in spite of changing 
political attitudes and hospital environments. There is a need for new methods 
to treat violent or threatening incidents in psychiatric wards. Norwegian PICUs 
use segregation nursing with the patients placed in separately locked areas 
with staff. This model may be an alternative to seclusion. Controlled trials 
regarding effects of principles and facilities for such treatment are lacking. The 
general aim of the present study was to investigate effects of facilities for 
segregation, and several assumed risk factors in a Norwegian PICU.  
 
The current thesis is based on data from 118 consecutively admitted patients 
to the PICU at St. Olavs University Hospital, Trondheim, Norway. The thesis 
has the following conclusions: 
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Main conclusions 
 
1: Interior and furnishing like an ordinary home in the PICU create an 
environment with comparable treatment outcomes to the traditional dismal 
interior and has positive effects on many patients’ well being. Patient self-
rating were significantly in favour of the ordinary home interior compared to 
the traditional interior 
 
2: The principles of patient segregation in PICUs have favourable effects on 
behaviours associated with and the actual numbers of violent and threatening 
incidents. The changes in assessments of behaviour measured by differences 
in BVC ratings from baseline (admittance) to day 3 were significantly in favour 
of segregating the patients in the PICU compared to not segregating the 
patients in the same area. There were significantly lower reported incidents of 
violent or threatening incidents when using the PICU as a segregation area 
compared to not using the PICU as a segregation area.  
 
3: In PICUs substance use is associated with favourable outcomes compared 
to patients not using substances. There was a significant difference in the 
changes of GAF-S –symptom ratings from admittance (baseline) to day three 
between the patient groups with or without a substance use diagnosis. The 
largest increase was in the patient group with a substance use diagnosis 
indicating more reduction of symptoms.  
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4: Threatening and violent incidents are not common acute manifestations of 
recent substance use in PICU populations. There was no significant 
difference in the number of threatening or violent incidents between the 
patient groups with or without a substance use diagnosis. 
 
5: Substance use predicts shorter length of inpatient stay in PICU populations. 
The mean length of stay in the PICU was significantly shorter in the patient 
group with a substance use diagnosis compared to the patient group without a 
substance use diagnosis. 
 
6: In PICUs prediction of short-term aggressive and threatening incidents 
should be based on clinical global judgement, and instruments designed to 
predict short-term aggression in psychiatric inpatients. In the hierarchical 
multiple linear regression analysis the global clinical evaluation from the 
physician on duty, the nurse clinicians’ global evaluation of “intensity of testing 
out and pushing limits”, and the observer rated scale scoring behaviours 
predicting imminent violence in psychiatric inpatients (BVC), were the factors 
positively associated with short-term threatening and violent incidents. 
 
7: The predictive properties for BVC in the PICU-setting are satisfactory for 
the first three days after a single rating at admittance.  
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Additional conclusions: 
 
1: Patients who have experienced segregation settings like seclusion have 
desires for alternative treatment conditions. These desires are to a large 
extent met by Norwegian PICUs. These PICUs are effective. 
 
2: In the architecture and design of PICUs it is important to take into 
consideration the possibilities for segregation of patients. 
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1.0 General introduction. 
 
 
1.1 History. 
 
 
Principles of treatment of behaviourally disturbed patients have been 
described from ancient times. Soranus gave a classic description of it in the 
second century A.D. He suggested: “Have the patient lie in a moderately light 
and warm room. The room should be perfectly quiet, unadorned by 
paintings…do not permit many people, especially strangers, to enter the 
room, and instruct the servants to correct the patients’ aberrations while giving 
them a sympathetic hearing…And if the patient begins to get out of bed and 
cannot easily be restrained, or distressed especially because of loneliness, 
use a larger number of servants and have them covertly restrain him by 
massaging his limbs: in this way they will avoid upsetting him. If the patient is 
excited when he sees people, bind him without doing any injury” (Conolly 
1964, Hodgkinson 1985). Soranus focused on the need to control the patients’ 
behaviour and the reduction of sensory and emotional stimuli. These 
measures should be conducted in an ethical acceptable manner. In 1794 
Philippe Pinel broadened these concepts in his “Memoir on Madness”. He 
appealed for asylums where the mentally ill could be treated with decency, 
gave optimistic prognoses and principles for therapy, and pointed out the 
balance between safety, patients’ rights and the nonpunitive use of coercive 
measures: “The true principles of managing the insane in a psychologically 
sensitive manner are also well understood…I mean a kind of supervision 
adapted to the danger of their madness, the prevention of dangerous 
consequences  of their impetuous outbursts without any mistreatment. If a 
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madman suddenly experiences an unexpected attack and arms himself…, the 
director – always mindful of his maxim to control the insane without ever 
permitting that they be hurt – would present himself in the most determined 
and threatening manner but without carrying any kind of weapon…At the 
same time the servants converge on him at a given signal, from behind or 
sideways, each seizing one of the madman’s limbs…Thus they carry him to 
his cell while thwarting his efforts and chain him if he is very dangerous or 
merely lock him up…The employees are expressly forbidden to retaliate even 
if they are hit..(P. Pinel, 1794, translated by Weiner (Postel 1981, Weiner 
1992). 
The last fifty years models of psychiatric care have been based on the ideal of 
a therapeutic milieu or community. There has been a general progression 
towards an open ward policy. Together with major advances in 
psychopharmacology this has changed the treatment and care offered in 
psychiatric facilities (Angold 1989, Greenblatt et al 1980, Crowhurst & Bowers 
2002). Altered treatment has led to an area of deinstitutionalization, and the 
psychiatric in-patient care is now mainly designed for short-term treatment of 
the severely mentally ill (Wing 1981).   
1.2   Patient populations in psychiatric acute units and Psychiatric 
Intensive Care Units. 
The psychiatric acute departments have become intensive units serving 
patients with a broad spectrum of psychiatric conditions (Breslow et al. 2000). 
Patients with most florid psychiatric symptoms are admitted to Psychiatric 
Intensive Care Units (PICUs) (Beer et al. 2001, Dix 2005). The typical 
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contemporary PICU patient presents in severe crisis often complicated by 
substance use, polypharmacy, behavioural dyscontrol and multiple axis 1 
diagnoses (Zealberg & Brady 1999). 
The term PICU has been used in the US and Western Europe for the last 30 
years. It was first used by Rachlin in 1973.  He analysed the need for a closed 
ward in an open hospital opened 1970 in New York (Rachlin 1973). The need 
for PICUs progressed parallel to the shift towards open ward policy. A minority 
of acutely disturbed and behaviourally disordered patients needed treatment 
not offered in open wards. PICUs were a way to provide theses patients with 
relevant environments and resources (Crowhurst & Bowers 2002). PICUs 
were meant to be “locked wards” for local patients, many of whom had not 
offended but needed a degree of security to help effectively manage 
problematic behaviours. PICUs specialize in the short term intensive care and 
treatment of particularly disturbed patients (Ryan & Bowers 2005). PICUs are 
facilities that generally have 12-15 beds, and a high nurse to patient ratio 
(Beer et al 1997). The size and architecture of PICUs differ, but generally the 
trends are like in the UK where large Victorian institutions have been 
decommissioned in favour of new smaller built accommodations (Dix 2005). 
Many PICUs have been developed by local services and there have been no 
national guidelines.  
 
Important ambitions for a PICU, aside from providing the necessary diagnostic 
and acute therapeutic help, is to control inappropriate behaviours, and provide 
its’ services in an environment which assists the patients’ recovery and is 
acceptable to patients, health workers and the general society. This 
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combination of efforts may sometimes seem contradictory, but a continuous 
strive towards these ideals is demanded. 
  
 
1.3 Aims for treatment in psychiatric acute units and PICUs. 
 
Psychiatric acute units and PICUs focus on acute treatment, function and 
behavioural disturbances. Psychopharmacology (Cornwall et al 1996, Hilliam 
& Evans 1996, Raja & Azzoni 2000), different forms of psychotherapy 
(Crowhurst & Bowers 2002, O´Brien & Cole 2004), and a therapeutic milieu 
are cornerstones in the treatment. Different levels of segregation are 
commonly used as management techniques. Primarily segregation is used for 
containment of patients with problematic behaviours. Patients and staff need 
to be protected from impending or further violence generated by disturbed 
patients. The disturbed patients themselves must be protected against self-
injury and the potential consequences of injury done to others such as guilt or 
reprisal from injured parties. Secondly it is used to obtain a decrease in 
sensory and emotional input (Gutheil 1978, Hodgkinson 1985). The latter is 
based on the belief that certain patients suffer from excessive mental activity, 
which is increased by external stimuli (Mason 1993).  The need for decrease 
in sensory stimuli stems from the hypothesis that psychotic patients have an 
increased sensitivity to sound, smell and touch. Disturbed patients may also 
be vulnerable to emotional demands in relationships with staff and other 
patients. Particularly with paranoid patients such demands may be open to 
misinterpretations. Segregation restricts such demands. Segregation is thus 
seen both as an emergency management procedure and a treatment 
technique. 
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 Psychiatric acute wards use different segregation procedures. It is common 
to have either seclusion rooms or separation areas separated from the other 
parts of the wards. The segregation procedure differs from keeping the patient 
alone in the seclusion room to using segregation nursing, placing the patient 
in a separately locked area with staff.  
 
1.4       Factors affecting treatment. 
 
The influence of the ward atmosphere on the treatment of psychiatric in-
patients has been acknowledged for decades. Psychological, social, and 
physical aspects of the ward milieu affect treatment outcome and patient 
satisfaction (Middelboe et al. 2001, Friis 1986, Melle et al. 1996). Patients in 
PICUs are also influenced by a complexity of environmental, social and 
psychological factors (Crowhurst & Bowers 2002). Physical environment, 
psychosocial climate, bed numbers, admission criteria, staff numbers, 
education of staff etc. are factors affecting treatment. 
 
 
 
1.5        Ethical considerations regarding treatment in acute psychiatric 
facilities. 
 Segregation of patients raises ethical and legal questions. Different authors 
have indicated that seclusion may have both potentially beneficial (Gutheil 
1978) and destructive (Hodgkinson 1985, Pilette 1978) effects. In a review of 
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seclusion Fisher (1994) found support for the assumptions that seclusion 
prevented injury and reduced agitation, but it could have serious deleterious 
physical and psychological effects on patients and staff. Violent behaviour or 
threats of violence are commonly accepted indications for coercive measures 
(Angold 1989, Fisher 1994), but often coercion like seclusion is used to 
control agitation or disorientation (Heilbrun et al 1995, Kaltiala-Heino et al 
2003). In most studies young, male patients suffering from psychosis or 
personality disorders have been most likely to be secluded or restrained 
(Betemps et al 1993, Fisher1994). In a Norwegian population restraint was 
shown to be targeted at young, male non-psychotic patients, while seclusion 
was used for older, male patients with an organic, psychotic disorder (Wynn 
2002). Patients tend to consider seclusion as punishment and a therapeutic 
measure with little value (Tooke & Brown 1992).  
 To manage violent and disruptive behaviours acute units and PICUs also use 
chemical, physical and mechanical restraints. Mechanical and physical 
restraints have both been reported to be associated with serious side effects 
and death of patients (Mohr et al 2003, Hem et al 2001, Paterson et al 2003). 
In a recent questionnaire study from 51 psychiatric emergency services in the 
US, Allen & Currier found that restraint was used with similar frequencies in 
rural areas, urban centres and university-based programmes (7-12%). Staffs 
generally agree that patients recall and have adverse reactions to restraints 
(Allen & Currier 2004). 
 
During the last years there have emerged new legislations, recommendations, 
court cases and professional guidelines to control the use of coercive 
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measures in psychiatry. The recurring message in all of these guidelines is 
the need to practice caution when applying seclusion or restraints 
(Appelbaum 1999, Dyer 2003, Sailas & Wahlbeck 2005). The European 
Committee for the Prevention of Torture and Inhuman or Degrading 
Treatment of Punishment (CPT) considers seclusion and restraints matters of 
particular concern given the patient population and potential for abuse. The 
CPT considers that seclusion is a practice which must be abandoned within a 
context of modern psychiatry (Council of Europe 2005). 
 
 
1.6   General problems in acute psychiatric practice 
 
In spite of international recommendations use of seclusion and restraints 
continue. Long term studies of the rate of seclusion indicate no decrease in 
spite of changing political attitudes and hospital environments (Crenshaw et al 
1997). There is a need for new methods to treat violent or threatening 
incidents in psychiatric wards (Sailas & Wahlbeck 2005). 
There has been a lack of evidence base and theoretical underpinning of the 
treatment in psychiatric intensive care (Dix 2005, Sailas & Fenton 2001). 
Many PICUs are criticised for poor environments, high levels of aggression 
and unsophisticated approaches to treatment (Zigmond 1995). 
Patients, therapeutic interventions, structures and management of PICUs 
have been described (Beer et al 2001, Crowhurst & Bowers 2002). Controlled 
trials or post occupancy evaluations regarding effects of PICUs are lacking. 
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2.0 Introduction to the present study. 
Different cultures have varying attitudes towards and procedures for 
segregation of behaviourally disturbed patients. In many countries seclusion is 
practised similar to ”solitary confinement” with the patient alone in a padded 
room.  Norwegian segregation practice is different with the use of segregation 
nursing. In this procedure the patients are placed in separately locked PICUs 
with staff. In these PICUs the patient are virtually never alone. The principles 
of stimulus reduction and segregation from other patients are quite similar to 
other segregation settings. 
Segregation nursing like the model from Norwegian PICUs may be an 
alternative to seclusion. Controlled trials or post occupancy evaluations 
regarding effects of principles and facilities for such treatment are lacking. 
 
2.1      Facilities for treatment 
The few studies published indicate that the physical environment in which 
treatment occurs has impacts on treatment processes and outcomes, and that 
there are interrelationships between physical environment and behaviour 
(Corey et al 1986, Davis et al 1979). Former studies indicate that altered 
physical design variables may be associated with favourable perceptions of 
ward atmosphere, and have therapeutic value (Whitehead et al 1984). Two 
studies have shown that redecorating psychiatric wards in a homely manner 
tend to lower both threatening behaviour and vandalism (Christenfeld et al 
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1989, Wilson et al 1983). Similar effects may be observable in other parts of 
society like schools, public houses, cinemas and apartments (Newman 1973).  
 
2.1.1   Effects of interior decorations 
 
The interior design and furnishings in areas for segregation in psychiatric 
acute wards are influenced by the wish to reduce the external stimuli and 
maintain safety. These areas are sparsely furnished with windows lacking 
curtains, naked walls without paintings or decoration, and living rooms without 
sources of stimuli like TV, radio, newspapers and flowers. Though the 
interiors differ between hospitals, these environments can often be regarded 
as hypostimulating and alienating (Niveau 2004). Reduction in sensory and 
emotional input may lead to relative sensory deprivation. Studies on sensory 
deprivation on psychiatric patients indicate that some patients may deteriorate 
in hypostimulating environments (Freedman & Greenblatt 1960). 
 
The interior design and furnishings of PICUs, separation areas or seclusion 
rooms are sparsely studied (Crowhurst & Bowers 2002). The description 
given by Soranus 2000 years ago still summarizes the principles of design in 
many present facilities (Hodgkinson 1985). In 1856 John Conolly described a 
room designed for violent or extremely excited patients (Angold 1989). Gutheil 
& Daly (1980) have indicated clinically based principles of seclusion room 
design focusing on “identifying the maximum stresses it will endure and 
building it to endure them over long periods of time”. Dix & Williams have 
given a review of design of PICUs with recommendations for e.g. layout, 
security, observation and safety (Dix & Williams 1996).To our knowledge no 
controlled studies or post-occupancy evaluations have been carried out.   
 24
CPT has in some cases defined seclusion as a form of ill-treatment because 
of poorly ventilated seclusion premises, no means for the patient to contact 
staff, unsuitable bedding, lack of windows and proper sanitary conditions 
(Council of Europe 2005). 
 
 
2.1.2   Effects of segregation 
 
There are lack of controlled studies evaluating the effect of segregation and 
seclusion (Sailas & Fenton 2001, Wright 2003). Some studies have reported 
no association between crowding and aggression (Hardie 1999, Lanza et al 
1994), while others have reported that increased inpatient numbers lead to 
more aggression against both staff and other patients (Kumar & Ng 2001, Ng 
et al 2001, Owen et al 1998, Palmstierna et al 1991). Excessive stimuli and 
environmental stress are reported to be associated with increased tendency 
towards violence (Hodgkinson 1985, Morken et al 1999).  
    Effects of ward space and architecture are sparsely studied. Palmstierna et 
al found that patients with schizophrenia were more likely to be aggressive in 
a crowded ward (Palmstierna et al 1991). In a second study the same authors 
did not find a decline in the frequency of aggression in spite of a reduction of 
the number of beds by 50% (Palmstierna & Wistedt 1995).  Nijman were 
unable to document a decline in aggressive incidents after extending space in 
a ward (Nijman & Rector 1999).  
 
2.2 Effects of substance abuse. 
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Studies from the US indicate that around 50 % of service users with mental 
illnesses also have substance use problems (Regier et al 1990). Prevalence 
rates are higher in inpatient populations and emergency services settings 
(Ridgely & Johnson 2001). European studies generally report somewhat lower 
prevalence rates (Phillips & Johnson 2003). Data from our own catchment 
area shows that 32 % of the patients admitted to the acute department suffer 
from substance use disorders (J. C. Fløvig, personal communication). In 
populations of psychiatric in-patients substance use has been found to 
interfere with the expression and resolution of symptoms of psychiatric 
disorders, to induce or influence acute behavioural changes and to have 
significant effects on treatment outcome and costs (McKeown & Liebling 
1995, McNiel et al 1988, Sanguineti & Brooks 1992, Zealberg 1999). The 
findings in previous studies indicate that substance use among psychiatric in-
patients is associated with hostility and assaultiveness (Drake et al 1993, 
Sandford 1995). 
Studies of substance abuse conducted in PICU populations are sparse. In 
PICUs and emergency services substance use patients constitute a very 
heterogeneous patient group, spanning from patients with independent mental 
disorders complicated by substance use to patients with psychoactive 
substance use induced disorders only (Lehman et al 1994). A study from two 
PICUs and nine open acute wards in inner London indicates the frequency of 
substance use in PICUs (Phillips & Johnson 2003).  Eighty-nine% of the 
patients reported to have had used illicit drugs or alcohol on the ward during a 
previous admission, and 83% had used substances during the current 
admission. 
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2.3 Threatening and violent incidents. 
 
Threatening and violent behaviour by psychiatric inpatients is a major concern 
in psychiatric practise. Aggression has negative consequences for patients 
and staff. Some studies indicate it as an increasing problem (James et al 
1990, Noble & Rodger 1989). Reduction of severity and incidence of 
threatening and violent incidents is important in order to improve quality of 
care in psychiatric facilities. Prediction of violence is therefore important in 
order to initiate preventive measures. Risk factors, predictors and accuracy of 
predicting violent or threatening incidents among psychiatric inpatients are 
widely described (Steinert 2002).   
In PICUs, emergency services and acute wards violent incidents are frequent 
and short-term predictions of violence important (Walker & Seifert 1994). In 
these settings predictions based on clinical global judgement from 
experienced staff, or instruments designed to predict short-term aggression 
may be better than actuarial data drawn from past medical and social history, 
treatment conditions, behaviours and psychopathology (Nijman et al 2002, 
Bjørkdahl et al 2006). 
 
 
3.0 Research questions 
 
 
The general aim of the present study was to investigate effects of a 
Norwegian PICU with main foci on facilities for segregation, effects of 
substance abuse and prediction of violent and threatening incidents.  
The thesis aims at answering the following questions: 
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1:  Is it possible to change the hypostimulating, dismal interior decorations 
with pleasant, stimulating interiors? The aims of the first study were to 
compare effects on symptoms, behaviours, and treatment in patients who 
were admitted to two different interior decorations. 
 
2: Is segregation important?  The aim of the second study was to compare the 
effects on symptoms, behaviours, and treatment in patients who were 
admitted to a PICU with or without a segregation area. 
 
3: How important is substance use in the PICU? The aims of the third study 
were to investigate differences in symptoms, behaviours, therapeutic steps 
taken, and length of stay in the PICU between patients with or without a 
substance use diagnosis. 
 
4: We also wanted to investigate possible predictive factors for violent or 
threatening incidents during the first three days in the PICU population. 
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4.0    Materials and methods 
 
 
4.1    Recruitment of patients. 
 The acute department of Østmarka Psychiatric University hospital has a 
catchment area of 140000 inhabitants both from the city of Trondheim (50%) 
and rural areas (50%) in Sør-Trøndelag County. About 700 patients older than 
18 years suffering from acute psychiatric conditions are admitted each year.  
All acute admissions from the catchment area are received in one of the 
hospitals’ two equal, closed acute wards.  Acute admissions to other 
psychiatric hospitals occur only when inhabitants temporarily reside outside 
the catchment area at the time of admission. Only patients with acute 
psychiatric conditions are admitted to the department. Patients with 
intoxication alone are admitted to separate acute, short-term substance abuse 
treatment facilities. 
 
4.2 Setting 
 
           The study ward consists of an ordinary closed ward area (310 m2) and a 
PICU area (190 m2). The main entrance leads to the ordinary area of the ward 
consisting of two double patient rooms, two single patient rooms, staff and 
social rooms arranged along a corridor. In the end of the corridor a locked 
door separates the PICU area (Fig 1) from the ordinary area of the ward. 
The PICU area consists of two wings with sitting room, bathroom, WC, and 
two single patient rooms in each. The wings are separated by an entrance 
area, a dining room and a staff room in the middle. Two to four patients and 
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two to three nurses are present in the PICU area. The patients stay mostly in 
the wings together with nurses, and contact with other patients is limited.  The 
PICU area thus limits emotional and sensory stimuli and provides segregation 
from other persons. 
The wards had been renovated four years prior to the study. They were well 
kept and had few signs of damage.  Before the study both wings had 
traditional, sparse, hypostimulating interior design and furnishings. As part of 
the study one of the wings was redecorated and refurnished. The aims were 
to make it look, as much as security permitted, like an ordinary Norwegian 
home.  
 
 
4.3      Design 
 
Paper 1 is a prospective, semi-randomized clinical trial with control group. The 
patients were allocated to the refurbished wing or to the traditional wing in the 
PICU by a predetermined rule: They were admitted to the wing with fewest 
patients, or with even numbers, to the wing which did not receive the previous 
patient. While this is not true randomization, it does deprive the staff the 
power to influence the composition of the groups. In addition; since it is not 
obvious that this allocation scheme will skew group composition in any 
particular direction it may serve several of the purposes of randomization.  
Paper 2 is designed as a prospective “quasi-experimental” study, where two 
comparable groups of patients are given two different types of treatment. The 
group assignments are not created through randomization. Patients entered 
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the different groups based on which period of time they were admitted to 
treatment. 
Paper 3 is a descriptive longitudinal study with control group based on the 
patients identified in paper 2. The patients who fulfilled criteria for any 
substance use disorder according to ICD-10 Diagnostic criteria for research (F 
10.00 – F 19.99) (WHO 1993) were allocated to the study group regardless of 
other diagnoses. The patients who did not fulfil criteria for any substance use 
disorder, constituted the control group. 
 
Paper 4 is a descriptive longitudinal study with control group based on the  
patients identified in paper 2. The patients who had a threatening or violent 
episode during the stay as measured by the SOAS-R (Nijman et al 2005, 
Palmstierna & Wistedt 1987), constitute the study group. The rest constitute 
the control group. Clinical data at admittance are related to the outcome 
measure. 
 
4.4        Study populations 
 
In the periods from November 13th 2000 to March 25th 2001 (inclusion 1) and 
from October 1st 2001 to March 21st 2002 (inclusion 2), 56 and 62 patients 
were included. One patient was excluded due to senile dementia. 
Paper 1 is based on the patients from inclusion 1. The patients were admitted 
to a PICU with closed segregation conditions. The door between the ordinary 
area and the PICU area was permanently locked, and the doors between the 
entrance and the wings in the PICU area were permanently closed (Fig 1). 
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The numbers of patients semi-randomized to refurbished and traditional wings 
were 31 and 25. 
Paper 2 is based on patients from both inclusions.  The patients in inclusion 2 
were treated with the door between the ordinary area and the PICU area 
removed, and the doors leading to the wings kept permanently open (Fig 1). 
Thus no patients were segregated during inclusion 2. The patients from 
inclusion 1 function as control group. 
 
Paper 3 is based on patients from both inclusions. The numbers of patients 
with and without a substance use diagnosis were 43 and 75. 
 
Paper 4 is based on patients from both inclusions. The first three days a total 
of 3 (inclusion 1) and 19 (inclusion 2) violent or threatening incidents were 
recorded among 3 (inclusion 1) and 10 (inclusion 2) patients (11%). 
 
 
   
 
4.5   Procedure 
During both inclusions all patients admitted to the acute ward were evaluated 
by the physician on duty. The patients evaluated to be in need of stay in the 
PICU were included in the studies except patients with dementia, mental 
retardation or autism to a severe degree, and patients not speaking 
Norwegian or English. Criteria for discontinuation were different in the two 
inclusions. In the inclusion 1 condition patients who reacted verbally or 
physically negative in altered interior, or did not improve according to GAF 
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score after 10 days, were to be discontinued and admitted to the other ward. 
In the inclusion 2 condition patients in absolute need of segregation were to 
be discontinued from the study and segregated in the patient’s room together 
with staff. 
 
The patients’ needs for stay in PICU were rated on a scale with scorings1-4 (4 
representing absolute need). The reasons for PICU were recorded on a scale 
with four categories (patient’s own wish, need of close observation, stimuli 
reduction or control of behaviour (Appendix 1)). 
 
To estimate changes in symptoms of psychopathology, function and 
behaviour we used The Positive And Negative Syndrome Scale (PANSS) for 
schizophrenia with time criterion the last 24 hours (Kay et al 1987), the Global 
Assessment Scale Split version (S-GAF), and the Broset Violence Checklist 
(BVC) (Almvik & Woods 1999). The patients were assessed at admittance 
(baseline), day 3 and at discharge from the PICU (end-point). Specially 
trained ward nurses did all the ratings.  
The decision to transfer a patient from the PICU area to the ordinary area was 
a joint decision in the ward staff. In both inclusion 1 and inclusion 2 conditions 
patients were transferred to a patient room in the ordinary area. “Length of 
patient stay” was the total length of stay in the PICU area for all the patients. 
 
For patients who were discontinued from the study scorings at the time of 
discontinuation functioned as end point in every measurement except “Length 
of patient stay”. 
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Diagnoses according to ICD-10 Diagnostic criteria for research (WHO 1993) 
were set by consensus in the department’s staff, including at least three 
specialists in psychiatry of whom at least two personally knew the patient. 
 
 
 
4.5.1   Instruments 
 
BVC is a six-item observer-rated scale for scoring behaviours in psychiatric in-
patients (Busch-Iversen et al 1994, Linaker & Busch-Iversen 1995). It 
assesses the presence or absence of six behavioural states: confusion, 
irritability, boisterous behaviour, verbal threatening, physical threatening, and 
attacking objects. The instrument includes short definitions of the six 
phenomena, and each of the six items is scored for its presence (1) or 
absence (0). Studies in different in-patient settings have yielded satisfactory 
predictive accuracy (Abderhalden et al 2004, Almvik et al 2000, Bjørkdahl et 
al 2006). Higher BVC scores predict imminent violence.  
Violent or threatening incidents were recorded with Staff Observation 
Aggression Scale-Revised (SOAS-R) (Nijman et al 1999, Palmstierna & 
Wistedt 1987). The SOAS comprises five columns pertaining to specific 
aspects of aggressive behaviour (i.e. provocation, aggressive means used by 
the patient, the target of aggression, consequences and measures taken to 
stop aggression). The SOAS – R has a severity scoring system ranging from 
0 to 22 with higher scores indicating greater severity. Reviews of studies of 
psychometric properties indicate fair inter-rater reliability and validity for SOAS 
assessments (Nijman et al 2005).  
The Positive And Negative Syndrome Scale (PANSS) for schizophrenia is a 
widely used 30-item instrument measuring positive psychotic, negative and 
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general psychiatric symptoms in patients primarily suffering from 
schizophrenia (Kay et al 1987). The psychometric properties of the instrument 
are evaluated in several studies, and the main results shows that the PANSS 
scorings are normally distributed, they have good inter-rater reliability; and the 
positive and negative syndromes are independent constructs with their 
respective subscales holding high concurrent validity in relation to other 
specific scales designed to measure negative or positive symptoms (Peralta & 
Cuesta 1994). Usually the time criterion in PANSS assessments is the recent 
week. Due to the fast changes in symptoms in the PICU, we chose time 
criterion the last 24 hours.  
Since psychometric properties of The PANSS used in a PICU-population with 
time criterion last 24 hours is not previously tested, Hansen & Strand 
evaluated this in a separate pre-study. Through scorings of 3 video-taped 
patient interviews (PANSS training 1989) and assessments of 12 
consecutively admitted in-patients, the trained ward nurses demonstrated 
excellent inter-rater reliability both for total PANSS sum, sums of positive  
(Pearson's r= 0.96), negative (r= 0.84) and general subscales (r= 0.87) as 
well as the different 30 single items (Hansen & Strand 2000). 
 
S-GAF is based on DSM-4’s GAF (APA 1994) and is a two-item scale 
measuring global symptoms and functioning separately. The psychometric 
properties of the S- GAF are not investigated properly though the scale is 
widely used. The one item GAF with combined evaluation of symptoms and 
function is widely investigated. The psychometric properties are found to be 
 35
satisfactory to measure changes and outcomes at the group level (Friis et al 
1993, Melle 2000, Soderberg et al 2005, Yamauchi et al 2001).   
 
In inclusion 1 the patients rated their treatment satisfaction on an 8-item visual 
analogue scale with scorings 0-10 (10 representing the best value) 
immediately after discharge from the PICU (Appendix 3). This scale also has 
an English version (Appendix 4). The psychometric properties of these 
instruments are not tested. 
 
In paper 4 the item “physician’s prediction” was constructed by combining the 
two items at physician on duty’s evaluation at admittance. The item “need for 
PICU” has a scale with scorings 1-4 with increasing value indicating 
increasing need. The item “reason for admittance to PICU” has four 
categories: 1: patient’s own wish, 2: need of close observation, 3: reduction of 
stimuli, or 4: control of behaviour.  “Physician’s prediction” is an index defined 
by giving all the patients from category 4 (control of behaviour) the scorings 
on “patients’ need” of PICU, and the rest of the patients value 0. “Physicians 
prediction” thus has scorings 0-4 with increasing value indicating increasing 
probability for violent or threatening incidents. 
 
In paper 4 we assumed that the use of segregation for inclusion 1 patients 
and not for inclusion 2 patients might be of importance and introduced the two 
time-periods as a factor named “Effect of segregation”. 
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Therapeutic and control steps taken, and nurses observation were coded 
daily on a 23-item checklist. These included among other things all prescribed 
medication, side effects, staff contact time, formal restrictions, use of 
newspapers, and visits from relatives (Appendix 5). Specially trained ward 
nurses filled in the checklists. 
 
 
 
 
4.5.2   Assessments of substance use and medication 
.  
The patients were systematically examined for substance use and medication 
by physician on duty at admittance, in evaluation with ward psychiatrist the 
first weekday after admittance and at discharge from PICU. The families and 
general practitioners of many of the patients were also interviewed about 
substance use. In inclusion 1 urine samples were analysed on clinical 
suspicion of substance use. In inclusion 2 all admitted patients had urine- and 
blood samples taken within a few hours of admission. The urine samples were 
analysed with liquid chromatography with mass spectrometry. The samples 
were analysed with regard to amphetamine, amphetamine-similar substances 
(including methamphetamine), barbiturates, benzodiazepines, buprenorfine, 
cannabis, ethanol, cocaine, LSD, opiates and phencyclidine. The test can 
specify each substance and medication found in the test. The level of creatine 
was assessed as a measure of authenticity of the sample.  In cases with 
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positive urine samples, quantification of the same substances in blood was 
done. 
The reports from the laboratory were available a week after admittance, and 
the clinicians were not aware of the results from the analysis in the acute 
treatment period. 
 
4.5      Statistical analyses 
 
All data were analysed using the Statistical Package for the Social Sciences 
(version 10.0 and 11.0). 
In all papers differences between groups of patients were assessed by 
Students t-test for comparing means on continuous scales and Mann-Whitney 
U-test for differences on non-parametric scales (two-tailed). Chi-square was 
used for comparing frequencies.  Missing values for single items on the rating 
scales were substituted by the mean for continuous scales.  
 
In paper 3 we did post hoc regression analyses to assess the influence of 
differences in sex ratio and the presence of affective or schizophrenic disorder 
on the differences between the two groups. 
 
 In paper 4 Pearson’s correlation were used to examine all predictors for the 
presence of collinearity among predictors. Hierarchical multiple linear 
regression was performed to determine the factors that best predicted SOAS 
incidents after controlling for sex, age and diagnoses. A 3-step, hierarchical, 
multiple regression analysis was carried out.  
 38
Before study 1 power assumptions was performed. The number of subjects in 
each group was estimated with regard to the possibility to discover clinically 
important differences in GAF score > 10. We estimated standard deviation = 
10, significance level = 0.05 and power = 0.95 indicating a number of subjects 
per group = 27. 
 
 
4.6      Study approval 
 
All patients in the study were acutely admitted and in need of closed ward.  
Their mental condition excluded informed consent and it was not attempted 
obtained. With this exception, the study was conducted in accordance with the 
declaration of Helsinki (World Medical Association 2000). The study, including 
the lack of informed consent, was approved by “The Regional Medical 
Research Ethics Committee, Central Norway.” 
 
 
 
 
 
5.0      Results 
 
 
5.1       Paper 1 
 
 
Effects of different interior decorations in the seclusion area of a 
psychiatric acute ward. 
 
Arne E. Vaaler, Gunnar Morken and Olav M. Linaker. 
Nordic Journal of Psychiatry 2005; 59: 19-24. 
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Objectives: To compare development in symptoms, behaviours, treatment 
and patient satisfaction of a traditional interior and an interior furnished like an 
ordinary home in a seclusion area. 
Methods: A naturalistic sample of 56 consecutive patients admitted to an 
acute ward were allocated to two different seclusion areas, one with a 
traditional interior and one decorated as an ordinary home. Symptoms of 
psychopathology, therapeutic steps taken, violent episodes, length of patient 
stay and patient satisfaction were recorded. 
Results: There were no differences in score changes on The Positive and 
Negative Syndrome Scale for schizophrenia, The Brøset Violence Checklist, 
or Global Assessment of Function split version scale between the two patient 
groups. Therapeutic steps taken, number of violent episodes, and length of 
patient stay was also similar. Female patients preferred an ordinary home 
interior. 
Conclusion:  Interior and furnishing like an ordinary home in the seclusion 
areas created an environment with comparable treatment outcomes to the 
traditional dismal interior and had positive effects on many patients’ well 
being, at least among the women. The traditional beliefs that a sparsely 
decorated interior is a method to reduce symptoms of psychopathology and 
dangerous behaviours were not supported by our data. 
 
 
 
 
5.2 Paper 2 
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Effects of a Psychiatric Intensive Care Unit in an acute psychiatric 
department. 
Vaaler A E, Morken G, Fløvig JC, Iversen VC, Linaker OM 
Nordic Journal of Psychiatry 2006; 60: 144-149. 
Objective: Psychiatric acute units use different levels of segregation to satisfy 
needs for containment and decrease in sensory input for behaviourally 
disturbed patients. Controlled studies evaluating the effects of the procedure 
are lacking. The aim of the present study was to compare effects in acutely 
admitted patients with the use of segregation in a Psychiatric Intensive Care 
Unit and not in a psychiatric acute department. 
Method: In a naturalistic study one group of consecutively referred patients 
had access only to the Psychiatric Intensive Care Unit, the other group to the 
whole acute unit. Data were obtained for 56 and 62 patients using several 
scales. 
Results: There were significant differences in reduction of behaviour 
associated with imminent, threatening incidents (Broset Violence Checklist), 
and actual number of such incidents (Staff Observation Aggression Scale-
Revised) in favour of the group that was segregated in a Psychiatric Intensive 
Care Unit. 
Conclusion: The principles of patient segregation in Psychiatric Intensive Care 
Units have favourable effects on behaviours associated with and the actual 
numbers of violent and threatening incidents. 
 
5.3 Paper 3 
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Substance abuse and recovery in a Psychiatric Intensive Care Unit. 
 
Arne E. Vaaler, Gunnar Morken, John Chr. Fløvig, Valentina C. Iversen,  
Olav M. Linaker, 
General Hospital Psychiatry 2006; 28: 65-70. 
Objectives: To compare development in symptoms, behaviours, function and 
treatment between patients with or without a substance use diagnose in 
a Psychiatric Intensive Care Unit.  
Methods: A total of 118 admitted patients were assessed at admittance, day 3 
and at discharge from the Psychiatric Intensive Care Unit. Symptoms of 
psychopathology, therapeutic steps taken, violent episodes, and length of 
patient stay were recorded. 
Results: Thirty-six of the men (53.7%) and seven of the women (13.7%) had a 
substance abuse disorder. Substance use patients had less psychiatric 
symptoms at admittance and showed faster symptom reduction, more 
favourable and faster improvement of function, and a shorter length of stay. 
Except for symptom reduction and shorter length of stay, these differences 
were largely due to differences in sex and diagnoses in the two groups. 
Conclusion: In a naturalistic group of patients in a Psychiatric Intensive Care 
Unit substance use is associated with favourable outcomes compared to 
patients not using substances. 
 
5.4 Paper 4 
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Short-term prediction of threatening and violent behaviour in a 
Psychiatric Intensive Care Unit. 
Arne E. Vaaler, Valentina C. Iversen, Gunnar Morken, John Chr. Fløvig,  
 
Olav M. Linaker. 
Submitted. 
Objectives: The aims of the present study were to investigate possible 
predictive factors for threats and violent incidents the first three days in a 
PICU population based on evaluations done at admittance. 
Methods: In 2000 and 2001 a total of 118 consecutive patients were assessed 
at admittance to a PICU. Actuarial data from present admission, global clinical 
evaluations by physician and clinical nurses first day, and environmental 
factors were related to the outcome measure Staff Observation Aggression 
Scale-Revised (SOAS-R). Hierarchical multiple linear regression analyses 
were performed to determine the factors that best predicted SOAS-R 
incidents. 
Results:  The final hierarchical regression analysis gave an R = .59, F (2, 106) 
= 5.17, p< .001. The global clinical evaluations and an observer scale scoring 
behaviours that predict short-term violence in psychiatric inpatients (The 
Broset Violence Checklist) were effective and more suitable than actuarial 
data in predicting short-term aggression. Environmental factors like 
segregation of patients in the PICU were important. 
Conclusion: In a naturalistic group of patients in a PICU prediction of 
aggressive and threatening incidents should be based on clinical global 
judgement, and instruments designed to predict short-term aggression in 
psychiatric inpatients. 
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6.0      Discussion 
 
 
 
 
 
 6.1 Methodological strengths 
The studies are strengthened by the prospective design. In all studies we look 
at a naturalistic patient population from a defined catchment area. PANSS, 
GAF-S, BVC and SOAS-R are robust and validated psychometric 
instruments. The routine screening for substance abuse has been 
comprehensive. Therapeutic and control steps taken have been controlled for 
through detailed, daily assessments. 
The study changed as little as possible of the daily routines of the department.  
The admissions, flow of patients, treatment and staff resources were 
unaltered. The same nurses and the staff treated patients from all the study 
and control groups thus making environmental differences between the 
groups limited. 
6.2 Methodological weaknesses 
 
6.2.1 Use of mechanical and chemical restraints 
 
The study PICU uses physical, mechanical and chemical restraints to a 
limited degree as needed. Both in inclusion 1 and 2 two patients were 
mechanically restrained for short times. Totally three patients were chemically 
restrained during the inclusions (Zuclopenthixole acetate). The uses of 
restraints were evenly distributed between the patient groups. We can not 
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exclude that the use of restraints have had effects on single parameters like 
SOAS-R incidents. 
 
6.2.2 Evaluation by physician on duty 
 
 
All acutely admitted patients were evaluated by the physician on duty. The 
patients evaluated to be in need of stay in the PICU were included in the 
study except patients filling criteria for exclusion. The physician on duty have 
made a global impression of the patients’ clinical condition and rated the need 
and reason for admittance to PICU. The inclusion in the study is thus not 
based on a validated instrument, but it merely reflects the main outcome of 
what goes on in the mind of the experienced clinician in the first encounter 
with the patient and reflects the naturalistic setting for the studies. There were 
no violent or threatening incidents reported among the patients evaluated to 
not be in need of the PICU. There were no patients evaluated not to be in 
need of PICU who later at the same admittance deteriorated needing PICU. 
Therefore it is reason to believe that the number of patients in need of PICU 
not included in the study was limited. We can not exclude that some patients’ 
need for PICU were exaggerated by the physician on duty with the 
consequence of admittance to PICU.  
 
6.2.3 Allocation of patients in inclusion 1 
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Paper 1 is based on inclusion 1 where the patients were allocated to the 
refurbished wing or the traditional wing following a predetermined rule. They 
were admitted to the wing with fewest patients, or with even numbers to the 
wing which did not receive the previous admittance. True randomization 
would have meant that every patient had had the same possibility of 
admittance to either wing regardless of how many patients that already were 
admitted to the wing. Since either wing only has two rooms, we could easily 
have had the situation of randomizing patients to a filled up wing while the 
other wing was vacant. In such a situation we would be obliged to discontinue 
the patient from the study, and admit the patient to the other ward. This would 
increase the number of discontinuations and interfere with our interpretations. 
These considerations made true randomization complicated. 
 
6.2.4 Completion of the patient-rating VAS-scale 
The patient-rating VAS-scale in paper 1 was completed by 55 % of the 
patients. One of the reasons for the low figures was that the scale was 
administered immediately following the patients’ discharge from the PICU, 
and many still suffered a substantial symptom pressure. We thus must 
evaluate the patient preferences with caution. This reflects some of the 
problems with self-rating scales in the PICU populations. The patients’ ability 
for self rating is limited due to their psychiatric conditions and affected 
cognitive functions (Linaker & Moe 2005).   
 
6.2.5 Lack of randomisation  
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In paper 2 the use of a naturalistic design without the use of randomisation 
compromises the interpretation of the study. A proper randomisation would 
have meant that every patient should have been randomised to the two 
different conditions which then, necessarily, had to be arranged in two 
different wards. Patients in acute psychiatric units are influenced by a 
complexity of environmental, social and psychological factors. A design with 
randomisation would have led to exposure to two different environments 
including staff. We considered the importance of these factors so substantial 
that it would have been difficult to interpret the results. In paper 2 data 
collection was conducted during the same time periods in two consecutive 
years thus taking into account seasonal variation of human mood, behaviour 
and psychopathology (Morken 2001). All admitted patients were evaluated for 
inclusion and only one patient was excluded. In the two groups levels of 
symptoms, function, behaviour; the numbers of therapeutic steps taken and 
nurses’ observations; and diagnoses were not different. We believe that these 
factors strengthen our interpretation of the main result. 
 
6.2.6 The detection rate of substance use.  
 
Paper 3 rely on investigation on substance abuse. Many studies have found a 
low detection rate of substance use in psychiatric treatment (Hansen et al 
2000). We have used a prospective design where all patients are 
systematically examined for substance use both in inclusion 1 and 2. In 
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inclusion 1 urine samples were analysed on clinical suspicion of substance 
use. In inclusion 2 all admitted patients had urine- and blood samples taken 
within a few hours of admission. There is a possibility for undetected 
substance use patients in inclusion 1. Since the fraction of substance use 
patients did not differ between the two inclusions, we believe that this number 
is very limited.  
 
6.2.7 Lack of availability and validation of instruments.  
 
Paper 4 uses the item “Physicians prediction” which is an index composed of 
the physician on duty’s global impression of the patients need and reason for 
admittance to PICU. This is not a validated instrument, but reflects the main 
outcome of the clinician’s impression from the evaluation at admittance. The 
nurse-rated item “intensity of testing out and pushing limits” has similar 
shortcomings. The SOAS-R incidents are few, but comparable to other 
studies. The mean severity score of the incidents is moderate. 
 
The availability of specific rating scales for PICU populations is limited. This is 
the reason for our use of PANSS scales with time-criterion 24 hours, and 
some self-made instruments like “physicians prediction” and “therapeutic and 
control steps taken, and nurses observation”. There is a need for new 
psychometric instruments tailored for the PICUs and emergency services 
populations. A problem in many e.g. PANSS items, is the need for presence 
of expressed, positive symptoms to give single items correct value (Hansen & 
Strand 2000). In PICUs patient often are initially reluctant to talk about their 
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thoughts or symptoms like paranoid ideas or depressive delusions in major 
affective episodes. In such situations the rater must assess the degree of 
symptoms as expressed by the patient. Such scorings may be too low. The 
psychotic anxiety often lifts quickly with proper acute treatment. The patients 
may then be more prone to express their delusions to staff. Comparisons or 
differences between multiple ratings in such situations can incorrectly indicate 
that the patients are deteriorating the first days. 
  
Patients in PICUs seldom primarily deteriorate the first days in PICUs. One 
exception might be conditions caused by progressive, organic diseases. Both 
in inclusion 1 and 2 we had a number of patients with increasing symptoms 
measured with PANSS or S-GAF from admittance to day 3. This is probably 
an artefact as mentioned. Clinicians also suggest that patients may sense the 
inadequacy of their impulses and control them to some degree in society, but 
may release the control attempts when hospitalized. Some caution is 
therefore warranted in the evaluation of the results of PANSS and S-GAF-S 
regarding symptom amelioration. 
 
6.2.8 Power assumptions.  
 
Before study 1 power calculations were performed. The number of subjects in 
each group was estimated with regard to the possibility to discover clinically 
important differences in GAF score (> 10). We estimated standard deviation = 
10, significance level = 0.05 and power = 0.95 indicating a number of subjects 
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per group < 20. We used “one-sided” statistics due to the observation that 
patients seldom deteriorated during the first few days in PICUs. The results 
eventually showed that “two-sided” statistics was necessary due to the 
research artefact mentioned in 6.2.7. We then ended with the n=27. Our 
inclusion 1 was then terminated with the lowest n = 25, and we thus ended up 
with a somewhat lower power in paper 1. 
 
6.2.9 Treatment factors not allowed for.  
The therapeutic and control steps taken, and nurses observation were coded 
daily on a 23-item checklist by the nurses on duty. This is not a psychometric 
instrument but merely a list of some of the factors associated with treatment in 
a PICU. There are multiple factors associated to treatment. Some of them are 
seemingly impossible to correct for. One example is the degree of lightning. 
The refurbished wing has multiple built-in spotlights while the traditional wing 
has a single lamp in the ceiling. The refurbished wing is directed south while 
the traditional wing is directed north. The patients in the refurbished wing 
therefore potentially had better light conditions. 
6.2.10 Low level physical and interactional measures.  
 
In PICUs nurses and staff uses a variety of low level physical and interactional 
measures in order to manage behavioural disturbances. These measures are 
not likely to be recorded or discussed neither in clinical practice nor research 
(Ryan & Bowers 2005). Examples are “non-touch guidance” like firm verbal 
instructions, “show of force” where two or more persons encircle the patient, 
“contact lead” where the patient are held by the arm and guided towards 
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intended locations etc. These measures were not recorded in the present 
studies. We can therefore not exclude that single patients or patient groups 
have been exposes to these measures in a higher degree than others, though 
the personnel were the same. 
6.2.11 Other effects  
Controlling all factors including the Hawthorne effect (benefit from improved 
routine care within the trial) is impossible. Just carrying out a project in this 
manner inspires staff to react differently and develop different coping-
strategies.  We also have reason to believe that the extensive use of routine 
rating scale measurements have affected treatment outcome and end-point 
measures in the study. This may have altered the impression of baseline 
scores (control group scores), but would less influence specific differences 
between study groups as they were all subjected to the same procedures.  
In inclusion 1 we had a total of 5 incidents of threatening and violent 
behaviour compared to the mean number of 43.4 incidents in the ward during 
the previous 5 years in a comparable period of the year. The registration of 
incidents was carried out carefully, and the reason for the low figures is not 
under-reporting. BVC measures were high in a substantial number of patients, 
and violent episodes should have been expected (Almvik & Woods 1999). We 
believe that the systematic and repeated questioning using rating scales 
disclosed important aspects of symptoms and made the staff able to take 
these into account in therapy.  
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6.3    General discussion 
 
 
The majority of inpatient programs for severely symptomatic psychiatric  
patients appear to find it impossible to operate without some form of 
segregation or physical or mechanical restraint (Fisher 1994). Not all 
professionals consider seclusion or restraints desirable or efficacious. There 
are ethical objections considering seclusion to be violating the patient’s basic 
rights of freedom and dignity (Council of Europe 2005, Pilette 1978). The 
message in new guidelines regulating coercive measures in psychiatric 
practice is the need to be cautious when applying seclusion or restraints 
(Appelbaum 1999, Dyer 2003, Sailas & Wahlbeck 2005).  
In a recent study from the US the authors summarize that experienced 
clinicians most commonly manage acutely violent patients with restraints and 
injections. The most frequently used medication turned out to be a 
combination of neuroleptics (haloperidol) and a benzodiazepine (lorazepam). 
These treatments were given irrespectively of diagnosis. The authors 
conclude that these practices involve risks of excessive coercion, 
overmedication, side effects and exacerbation of underlying medical 
conditions (Binder & McNiel 1999).  
Secluded patients themselves have expressed desires for more staff contact 
during seclusion, elimination of coercion and stigmatising conditions, and 
unlocked and more comfortable seclusion rooms (Hammil 1987).  Other 
authors have addressed the need for innovative approaches for PICU-patients 
such as “extra care areas” away from the main clinical areas, more non-
confrontational nursing treatments that allow expression of anger and 
confusion, and the need for a personal space within a safe, secure and 
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stimulus controlled setting (Crowhurst & Bowers 2002, Jeffery & Goldney 
1982). Norwegian PICUs with an interior decoration as described in paper 1, 
represent an alternative fulfilling many of the patients’ and professionals’ 
desires. The studies described in papers 1, 2 and 4 indicate that such PICUs 
are effective. 
 
6.4     Discussion paper 1 
 
Paper 1 highlights the effects of different interior decorations and different 
levels of visual stimuli in the PICU. Despite a detailed recording of patient 
functioning, behaviours, symptoms, and therapeutic steps taken by the staff, 
we failed to find negative effects of changing the traditional hypostimulating 
interior to a more pleasant and home like environment. 
Segregation of patients in hypostimulating environments is supposed to work 
through controlling and reducing external stimuli, and thereby reducing 
positive- and general psychiatric symptoms and length of patient stay. We 
found a non-significant tendency towards increased symptom amelioration in 
the patient group admitted to the hypostimulating interior measured with 
PANSS total and subscales but not with S-GAF and BVC. The use of S-GAF 
and PANSS has shortcomings in the PICU-setting. Considering this together 
with the slightly reduced power in our study, we still can not totally exclude 
that a hypostimulating interior ameliorates psychiatric symptoms slightly faster 
than a stimulating interior. However, our main findings with lack of substantial 
effects on symptoms, functioning and behaviour by ward redesign, 
corresponds well with the findings of Whitehead et al (1984). It is sometimes 
argued that providing a more humane clinical setting will hamper staff efforts 
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to discharge patients because of resistance to leave the ward. Our findings 
indicate that creating a pleasant environment does not generally increase 
length of patient stay. 
 
 
6.4.1          Patient satisfaction 
 
Patient satisfaction is one of the most important measures of the quality of the 
psychiatric services (Holocomb et al 1998, Røssberg 2005, Shipley et al 
2000). Paper 1 describes the patients’ self-rated treatment satisfaction scale 
(Appendix 3).  Due to methodological limitations the interpretation of the 
results must be done with caution, still it is interesting that the groups of 
patients admitted to the two interior conditions evaluated the ward similar on 
items measuring general social- and psychological climate. This indicates that 
patients were treated equally by staff regardless of condition. The differences 
were statistically significant only on two specific items measuring their 
reaction to the interior and how it affected them. The women accounted for 
most of this difference.   
 
The CPT calls for living conditions for psychiatric patients with particular 
attention to the decoration of both patients’ rooms and recreation areas, in 
order to give patients visual stimulation (Council of Europe 1998, Niveau 
2004). Patients’ rooms should be appropriately decorated and furnished 
(Council of Europe 2000, Kingdon et al 2004). Secluded patients themselves 
have expressed desires for elimination of stigmatising conditions and more 
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comfortable seclusion rooms (Hammil 1987).  The redecorated wing in the 
PICU represents an approach fulfilling some of these desires. 
 
6.5 Discussion paper 2 
 
6.5.1        Effects of segregation 
 
 
 
Paper 2 highlights the effects of the segregation procedure in the PICU. Our 
main findings were that use of the PICU as a separation area reduces 
behaviours associated with imminent violence as well as actual violent or 
threatening incidents. These findings were underscored by the fact that the 
non-segregated group in inclusion 2 initially had non-significantly lower 
scorings on BVC and PANSS. Fewer violent incidents and discontinuations 
could be expected, not more. The fact that the non-segregated group 
improved less in behaviour is strengthened by the discontinuation of 9 
patients with difficult behaviour from this group. These patients had 
deteriorating function and behaviour, and there is reason to believe that 
continuing their stay in non-segregated conditions would have continued this 
and thus strengthened our findings. 
 
6.5.2        Reasons for coercion 
 
 
Paper 2 gives support to the observations that coercion often is used to 
control agitation or disorientation (Heilbrun et al 1995, Kaltiala-Heino et al 
2003). The actual numbers of discontinuations in the groups were 0 (inclusion 
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1) and 9 (inclusion 2). The indications for discontinuation and segregation in 
the non-segregated group were aberrant non-violent behaviour. These are 
behaviours associated with increased risk of violent behaviour. This finding is 
similar to studies investigating reasons for seclusion. Violence is not always 
followed by seclusion, and non-violent behaviour is the most frequent 
antecedent to seclusion (Brown & Took 1992). 
 
6.5.3             Effects of ward space and architecture 
 
 
 
Studies on the associations between crowding and aggression are 
contradictory  (Hardie 1999, Lanza et al 1994, Kumar & Ng  2001, Ng et al 
2001, Owen et al 1998, Palmstierna et al 1991).  Effects of ward space and 
architecture are sparsely studied with similar contradictory results (Nijman & 
Rector 1999, Palmstierna et al 1991, Palmstierna & Wistedt 1995). The 
findings in paper 2 indicate that the important factor in reducing aggressive 
incidents in PICU populations is the need to separate single patients or 
patient groups in the ward.  The wards must therefore have possibilities for 
segregation. The importance of physical space in terms of square meters may 
be less important.   
It thus appears that subjective crowding, when a patient perceive an 
environment as crowded, may be more likely to precipitate violence than 
objective crowding (Kumar & Ng 2001). Subjective but not objective crowding 
has been associated with adverse mental health outcomes (Fuller et al 1996). 
An important determinant for the feeling of subjective crowding is “the body 
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buffer zone”, defined as the area that demarcates what is perceived as inner 
versus outer self (Horowitz et al 1964). “The body buffer zone” is a subjective 
sense that shapes our perception of crowding. It influences our perception of 
what our space is and when we feel that it is intruded by others (Kumar & Ng 
2001). Anxiety occurs when other persons enters “the body buffer zone”. 
Violent prisoners require a larger buffer zone than non-violent prisoners, and 
violent prisoners often misinterpret others as rushing towards them (Hildret et 
al 1971, Kinzel 1970). This may be important in the precipitation of violence in 
psychiatric patients with reduced impulse control (Kumar & Ng 2001, Nijman 
& Rector 1999).  
However, in inclusion 2 the non-segregated patient group was exposed to 
more factors than crowding possibly associated with violence (Hodgkinson 
1985, Morken et al 1999). Examples are more patients, staff and students 
around indicating increased auditive and visual stimuli, and emotional 
demands in relationships with staff, other patients and visitors. 
 
6.6 Discussion paper 3 
 
6.6.1        Substance use and outcome of treatment. 
 
 
Paper 3 highlights some effects of substance use in the PICU population. The 
main findings were that patients with a substance use diagnosis had a faster 
symptom reduction, a more favourable and faster improvement of function 
and a shorter length of stay in PICU compared to patients without a substance 
use diagnosis. The conclusions drawn from former studies indicating that 
substance use among psychiatric inpatients are associated with a variety of 
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adverse consequences (Drake et al 1993, McKeown & Liebling 1995) were 
not supported by the present data. On the contrary, our data indicate that 
substance use preceding admittance in PICUs are associated with favourable 
treatment outcomes in the present admission compared to patients admitted 
without substance use. 
 
6.6.2        Substance use and hostility. 
 
The findings in previous studies indicating that substance use is associated 
with hostility and assaultiveness (Drake et al 1993, Yesavage & Sarcone 
1983) also gained no support from our data. These differences between 
studies concerning hostility and assaultiveness are probably due to different 
populations. Drake et al mostly refer to outpatient populations. Our findings  
are similar to Dhossche’s (1999). His data was drawn from an emergency 
services patient population in a locked, short-term (up to 72 hours) holding 
area for extended evaluations. The main findings from these studies are that 
aggression is not a common acute manifestation of recent substance use in 
psychiatric emergency settings. 
 
6.6.3       Substance use and symptoms at admittance. 
 
The results from previous research indicate that substance use patients 
present more severe symptomatology at admittance compared to patients not 
using substances (Hansen et al 2000, Negrete et al 1986). In the present 
study from a PICU population both total PANSS scores and PANSS positive 
subscale including delusions, conceptual disorganisation and suspiciousness 
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were lower among substance use patients than the other patients at baseline. 
Even if these differences turned out to be dependent upon sex and 
diagnoses, our data do not indicate that substance use populations in PICU 
settings present more severe symptomatology. 
 
6.6.4       Substance use and length of stay. 
 
That substance use predicts shorter length of inpatient stay has been found in 
some studies (Herr et al 1991, Huntley et al 1998) but not in all (Chang et al 
1991). Paper 3 summarises that compared to the control group the patients in 
the substance use group had a length of stay in our PICU at only 40%. The 
trends in these findings are underscored by the findings in “therapeutic steps 
taken and nurses’ observations.”  The substance use group had a non-
significantly increased frequency of need to stay in PICU due to behavioural 
reasons at admittance. Even though the patients in this group displayed 
significantly less testing out behaviour and significantly more behaviour 
associated with ability to and interest in social activities the first three days. 
This trend remained after correction for sex and diagnoses. These factors 
were obviously important in the joint staff decision to discharge patients from 
PICU. The rapid improvement was not associated with increased support from 
family and friends since we found more visits and telephones to patients in the 
control group not using substances. 
Shorter lengths of stay and improved outcome in substance use groups 
compared to groups of non-users in acute and PICU populations have been 
explained by premature discharges of substance use patients (Greenfield et al 
1995). Our study does not support this.  We believe that shorter lengths of 
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stay in acute settings is partially due to a higher proportion of patients with 
psychoactive substance induced disorders in the acute settings compared to 
other inpatient or outpatient settings. However, Ries et al had similar results 
from a study in acute settings in a sample of patients with schizophrenia and 
substance use compared to schizophrenia without substance use (Ries et al 
2000). We believe that these findings are due to induction or amplification of 
symptoms by substance use leading to acute admission in the study group. 
Such symptoms may normalise rapidly after removal of abused substances, 
which would account for their shorter stays and improved outcomes. 
 
6.6.5       Additional interventions for substance use. 
 
The empirical evidence from other inpatient and outpatient samples strongly 
supports the adverse effects of substance abuse on the course of severe 
mental illnesses.  Long-time consequences are symptom exacerbation, 
increased hospitalisation, medication non-compliance, disruptive behaviour 
and decreased social functioning (RachBeisel et al 1999). Recent research 
has shown that psychiatric patients with substance use and a psychiatric 
disorder benefit more from an integrated treatment compared to treatment in 
psychiatric or substance use treatment facilities alone (Drake et al 1998, 
Swanson et al 1999). Randomised controlled clinical trials evaluating effects 
of integrated treatments in PICU populations are lacking. However, there is 
reason to believe that patients in PICU populations also would benefit from 
integrated treatments. Substance use groups in PICUs have short lengths of 
stay. In our study mean length of stay was 2.86 days. Additional interventions 
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during stay for this patient group have to be of short duration. Of special 
interest is therefore the study of Swanson et al (1999) indicating that the 
addition of a brief intervention (1 hour and 15 minute) based on motivational 
interviewing (Miller & Rollnick 1991) to an already intensive inpatient program 
led to better treatment adherence among dually diagnosed inpatients. 
However, the substance use groups in PICUs are heterogeneous with 
probable differences between countries and cities and rural areas (Lehman et 
al 1994, Phillips & Johnson 2003). The study by Lehman et al (1994) 
indicated that as much as 50 % of the substance use population in the acute 
ward did not have lifetime history of an independent mental disorder, but 
instead had psychiatric symptoms brought on by their substance use. These 
patients have different needs than patients with independent mental disorders 
like schizophrenia and major affective disorders and co-morbid substance 
use. Innovative solutions and development of integrated and tailored 
treatments for substance use are thus an aim for PICUs and acute wards 
(Phillips & Johnson 2003).  
6.7 Discussion paper 4. 
 
6.7.1        Prediction of violent or threatening incidents in PICUs. 
 
 
Paper 4 highlights prediction of possible violent or threatening incidents the 
first three days in a PICU population. Our results are in accordance with 
previous studies from acute wards. Generally the predictive value from 
actuarial data is limited. The global clinical evaluation “Physicians prediction” 
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from physician on duty, nurses’ global evaluation of “intensity of testing out 
and pushing limits”, and the observer-rated scale scoring behaviours 
predicting imminent violence in psychiatric inpatients (BVC), were more 
suitable for predicting short-term violent and threatening incidents in the PICU 
setting. 
 
Based on simple VAS-like scales McNiel et al (1988) and Apperson et al 
(1993) found that both attending psychiatrists and nurse clinicians were able 
to predict short-term violence in a reasonable degree in acute wards. In the 
present study the physician on duty and nurse clinicians have done 
independent evaluations at different times in a PICU-population. The methods 
and results from these studies have similarities. Therefore it is reason to 
believe that experienced staff members in acute settings are able to globally 
predict short-term violence in their patient populations. 
 
6.7.2              Violent or threatening incidents and psychopathology. 
 
 
 We found no association between SOAS-R ratings and psychopathology 
measured by PANSS total, PANSS subscales, and GAF-S. This finding is 
similar to Swett & Mills (1997). Steinert et al. found that scorings on the 
seven-item PANSS-positive scale correlated significantly with the number of 
threatening or aggressive incidents in a sample of acutely admitted in-patients 
(Steinert et al 2000).  Findings from studies using BPRS (Overall & Gorham 
1962) or PANSS are contradictory. Using the full scale PANSS is time 
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consuming but thorough, and this systematic questioning discloses important 
aspects of symptoms and make the staff able to take these into account in 
therapy. This may lower the number of violent or threatening incidents, and 
make conclusions from different studies difficult (paper 1). 
 
6.7.3           Effects of segregation. 
 
 
As expected from paper 2 a predictor for violent episodes was the item “Effect 
of segregation”. This item is a construct derived from the main difference 
between inclusion 1 and 2 which was the use of the PICU as a separation 
area or not (paper 2). We thus get similar results with the different statistical 
procedures used in paper 2 and 4. 
 
6.7.4                    BVC 
 
     The observer rated instrument BVC has previously been demonstrated to 
have satisfactory properties in forensic and acute settings (Abderhalden et al 
2004; Almvik et al 2000). In a PICU setting Bjørkedahl et al demonstrated that 
BVC to a high degree can predict severe violence within the next 24 hours 
(Bjørkedahl et al 2006). Paper 4 describes that the predictive properties for 
BVC in the PICU-setting also is satisfactory for the first three days after a 
single rating at admittance. BVC is short, practical and easy to administer in 
routine care. Systematic uses of standardized instruments like BVC give staff 
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opportunities to take preventive measures in limited numbers of high-risk 
patients.   
 
6.7.5               Admission status 
 
 Admission status did not predict SOAS incidents in the present study. This is 
contrary to findings from for instance Nijman et al who found a history of 
involuntary admission to be a predictor of aggressive behaviour (2002). This 
is probable partly due to different criteria for involuntary admissions. Some 
countries (e.g. Dutch law (Nijman et al 2002)) allow forced hospitalization only 
when a patient’s behaviour constitutes a direct and clear danger to the patient 
or others. Norwegian law extends this concept and also allows involuntary 
admissions in other cases of severe mental illness. 
 
6.7.6      Preventive measures on aggressive incidents. 
 
Several studies with different interventions have been conducted to assess 
the effects of preventive measures on aggressive incidents (Nijman et al 
1997). Conclusions are difficult to draw due to shortcomings in the research 
designs like lack of control conditions, possible under-reporting of aggressive 
incidents and staffs’ awareness of their wards being objects of research. 
There are also indications that systematic monitoring of aggressive incidents 
with for instance SOAS-R increases the staffs’ awareness of risk factors 
eventually leading to a decrease in numbers of incidents. Nijman et al (1997) 
compared the effects of several possible aggressive incidents-reducing 
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interventions in a closed psychiatric admissions ward with two similar control 
wards. The main results were a significant reduction of aggressive incidents in 
all the three wards. The reduction in the intervention ward and control wards 
were 62% and 43%, a difference that turned out to be non-significant. The 
results from paper 4 indicate that global experience in staff and structured 
instruments identify single patients where preventive measures should be 
considered. These measures should include physical separation of these 
patients from the other patients.  
 
7.0 Conclusions 
 
General findings. 
Patients who have experienced segregation settings like seclusion have 
desires for alternative treatment conditions. These desires are to a large 
extent met by Norwegian PICUs. 
 The studies described in papers 1, 2, and 4 indicate that such PICUs are 
effective. 
 
Additional general findings. 
Even though it was to a limited degree, the study PICU had to use chemical 
and mechanical restraints in the inclusion periods. There is a need for further 
studies in PICU populations that addresses the efficacy of different non-
coercive interventions to different types of PICU patients. 
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Main findings paper 1. 
 Interior and furnishing like an ordinary home in the PICU create an 
environment with comparable treatment outcomes to the traditional dismal 
interior and has positive effects on many patients’ well being. 
 
Additional findings paper 1. 
The traditional beliefs that a sparsely decorated interior is a method to reduce 
symptoms of psychopathology and dangerous behaviours are not correct at 
least regarding PICU populations. 
 
Main findings paper 2. 
The principles of patient segregation in PICUs have favourable effects on 
behaviours associated with and the actual numbers of violent and threatening 
incidents. 
 
Additional findings paper 2. 
In the architecture and design of PICUs it is important to take into 
consideration the possibilities for segregation of patients. 
 
Main findings paper 3. 
In a naturalistic group of patients in PICUs substance use is associated with 
favourable outcomes compared to patients not using substances. 
 
Additional findings paper 3. 
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Threatening and violent incidents are not common acute manifestations of 
recent substance use in PICU populations. 
Substance use predicts shorter length of inpatient stay in PICU populations. 
 
Main findings paper 4. 
In PICUs prediction of aggressive and threatening incidents should be based 
on clinical global judgement, and instruments designed to predict short-term 
aggression in psychiatric inpatients. 
 
Additional findings paper 4. 
The predictive properties for BVC in the PICU-setting are satisfactory for the 
first three days after a single rating at admittance. 
The predictive value from actuarial data drawn from past medical and social 
history, behaviours and psychopathology is limited. 
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Fig 1. 
A sketch of the acute ward with the Psychiatric Intensive Care Unit at Østmarka 
Psychiatric Department, St. Olavs Hospital. 
S=Sitting room;  D=Dining room;  SR=Staff room;  P=Patient room; E=Entrance. 
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Appendix 1.     Physician’s evaluation of the need and reason for  
                                      segregation (Norwegian version). 
 
 
 
 
                                                           SKJERMINGSBEHOV. 
 
          Registrering for prosjekt ”Effekt av interiør i skjermet avsnitt i psykiatrisk  
              avdeling”  STPS avd. Østmarka post 1. 
 
          Dette skjema fylles ut av vakthavende assistentlege og sykepleiere i fellesskap 
i forbindelse med innleggelsen på skjermet enhet. 
 
 
 
 
Pasient: …………………………..       Nummer i studien:…………………………. 
Dato:  ……………………………        Utfylt av :  …………………………………  
 
 
 
A :  Er det sannsynlig at denne pasient har behov for å være på skjermet avsnitt ? 
 
  Nei  
  Lite sannsynlig  
  Sannsynlig  
  Absolutt behov  
 
 
  
 
B :  Årsak til skjermingsbehov.* 
 
  Pasientens eget ønske  
  Behov for tett observasjon av diagnostisk eller medisinsk grunn  
  Behov for redusert mengde stimuli  
  Behov for å kunne kontrollere pasientens adferd  
 
*  Kryss av for alle aktuelle årsaker. 
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Appendix 2:  Physician’s evalution of the need and reason for  
                             segregation (English version). 
 
 
 
 
                                                NEED FOR SEGREGATION. 
 
          Registration in the project” Effects of the interior decorations in the 
separation area in Department of Psychiatry, St. Olavs Hospital, acute ward 1”. 
 
          This instrument is to be filled in by the physician on duty and nurses together 
in connection with the patient’s admittance to the separation area. 
 
 
 
 
Patient: …………………………..       Study ID:…………………………. 
Date:  ……………………………        Filled in by:  …………………………………  
 
 
 
A :  Is it probable that the patient has a need to be admitted to the separation area? 
 
  No  
  Little probability  
  Probable  
  Absolute need  
 
 
  
 
B :  Reason for admittance to separation area.* 
 
  The patient’s own wish  
  Need for close observation due to diagnostic or medical reasons  
  Need to reduce the amount of stimuli  
  Need to control the patient’s behaviour  
 
*  Indicate all reasons. 
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Appendix 3:    The patient rated treatment satisfaction scale (Norwegian version). 
 
 
                      HVORDAN  HAR  OPPHOLDET  PÅ  SKJERMET  VÆRT ? 
 
 
                        Vi ønsker å vite hvordan du har hatt det under oppholdet på      
skjermet.  Det gjør vi for å kunne bedre forholdene for pasientene som er der.  Vi vil 
ha oppriktige svar.  Ikke vær redd for å gi ris eller ros.   
                      .  Ditt skjema vil ha et ID-nummer som er kun til statistisk  bruk.  Det 
vil ikke bli koblet med ditt navn.    Dine svar vil bli behandlet anonymt.   
                       Etter hvert spørsmål har vi satt opp en linje.  Med å sette et kryss på 
denne linje viser du hvor misfornøyd eller fornøyd du er med det spørsmålet gjelder. 
(se eksempler under).    
                      Gi gjerne kommentarer under. 
 
Eksempler: 
A : Hvis du i spørsmål 1 er svært misfornøyd kan du krysse slik : 
Svært                                                                                                              Svært 
Misfornøyd   -x--------------------------------------------------------------------   fornøyd 
 
B :  Hvis du i spørsmål 1 er middels fornøyd kan du krysse slik: 
Svært                                                                                                              Svært 
misfornøyd   --------------------------------x-------------------------------------    fornøyd 
 
C :  Hvis du i spørsmål 1 er svært fornøyd kan du krysse slik: 
Svært                                                                                                                Svært 
misfornøyd   ---------------------------------------------------------------------x-    fornøyd 
 
Hvis noe er uklart, må du ikke nøle med å spørre personalet om mer informasjon eller 
hjelp. 
 
-------------------------------------------------------------------------------------------------------          
 
ID-nummer i studien : …………..                       Dato for utfylling: ………….. 
 
 
------------------------------------------------------------------------------------------------------- 
 
 
1 :     Hvor fornøyd er du med den hjelp du fikk for dine problemer ? 
 
Svært                                                                                                                   Svært 
misfornøyd    -----------------------------------------------------------------------       fornøyd 
 
( Eventuelle kommentarer) :   
…………………………………………………………………………………………
………………………………………………………………………………………… 
 
 
 
 
 
 
 
 
2 :   Hvordan var støtten du fikk av personalet under oppholdet ? 
 
Svært                                                                                                                  Svært 
dårlig         -----------------------------------------------------------------------          god 
 
( Eventuelle kommentarer) : 
…………………………………………………………………………………………
………………………………………………………………………………………… 
 
 
3 :    Hvor respektfullt synes du generelt at du ble behandlet ? 
 
Svært lite                                                                                                        Svært 
respektfullt   -----------------------------------------------------------------------   respektfullt 
                                                                                                                           
 
( Eventuelle kommentarer) : 
…………………………………………………………………………………………
………………………………………………………………………………………… 
 
 
 
4 :   Hvor fornøyd er du med maten du fikk på skjermet ? 
 
Svært                                                                                                                 Svært 
dårlig         -----------------------------------------------------------------------          godt 
 
( Eventuelle kommentarer) : 
…………………………………………………………………………………………
………………………………………………………………………………………… 
 
 
 
5 :   Hvordan likte du interiøret på den delen av skjermet (sidegangen og rommet)     
        hvor du oppholdt deg ? 
 
Svært                                                                                                                  Svært 
dårlig          -----------------------------------------------------------------------          godt 
 
( Eventuelle kommentarer) : 
…………………………………………………………………………………………
………………………………………………………………………………………… 
 
 
 
 
 
 
 
6 :   Hvordan virket interiøret på deg i den situasjon du var i ? 
 
Svært                                                                                                                   Svært 
dårlig           -----------------------------------------------------------------------          godt 
 
( Eventuelle kommentarer) : 
…………………………………………………………………………………………
………………………………………………………………………………………… 
 
 
 
 
7 :   Hvor  fornøyd er du  med informasjonen du fikk om virkninger og bivirkninger 
av medisinene du brukte under oppholdet på skjermet ? 
 
 
Svært                                                                                                               Svært 
misfornøyd    -----------------------------------------------------------------------   fornøyd                                    
 
( Eventuelle kommentarer) :  
…………………………………………………………………………………………
………………………………………………………………………………………… 
 
 
 
 
8 :  Hvor trygg kjente du deg under oppholdet på skjermet ? 
 
 
Svært                                                                                                          Svært 
utrygg     -----------------------------------------------------------------------     trygg 
 
( Eventuelle kommentarer ) : 
…………………………………………………………………………………………
………………………………………………………………………………………… 
 
 
 
 
 
                              Vær vennlig å sjekk at du har besvart alle åtte spørsmål med ett 
kryss på linjen for hvert av dem.  Legg skjemaet i vedlagte konvolutt og gi det til 
sykepleier.  Skjemaet blir bearbeidet anonymt av overlege Gunnar Morken. 
 
                              Mange takk for hjelpen! 
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Appendix 4:   The patient rated treatment satisfaction scale (English version). 
 
           YOUR  OPINION  ABOUT   THE   SECLUDED  AREA  OF                   
                                        THIS  HOSPITAL .
 
               In our efforts to improve patients’ stay in the secluded area of this hospital, 
we would like to know how you found your stay there.  This is important for us 
because we want to make conditions better for our future patients.  
               Your responses will be handled with strict confidentiality and will not in any 
way be connected to your name.  For statistical purposes the questionnaire has an ID-
number 
              We want honest answers.  Please, do not hesitate to either criticise or praise 
us.   
              After each question you will find a line (see examples below).  On this line, 
please indicate by a cross mark how satisfied or dissatisfied you felt.  Also, feel free 
to add further comments below in the indicated sections.   
 
Examples : 
A : If on question 1 you are dissatisfied you may put your cross like this: 
Very                                                                                                          Very 
dissatisfied   -x------------------------------------------------------------------  satisfied  
 
B: If on question 1 you are neither satisfied nor dissatisfied you may put your cross  
    like this: 
Very                                                                                                          Very 
dissatisfied   --------------------------------x-----------------------------------  satisfied 
 
C : If on question 1 you are very satisfied you may put your cross like this: 
Very                                                                                                          Very 
dissatisfied   ------------------------------------------------------------------x-  satisfied  
 
Please feel free to ask the hospital staff for further information or help, if needed. 
 
----------------------------------------------------------------------------------------------------- 
 
 
ID-number in the study:  ……………     Date:  ……………….. 
 
------------------------------------------------------------------------------------------------------- 
 
 
1 :   How satisfied were you with the help you got for your problems? 
 
Very                                                                                                             Very 
dissatisfied   -----------------------------------------------------------------------  satisfied 
 
(Comments if you like): 
…………………………………………………………………………………………
………………………………………………………………………………………… 
 
 
 
 
 
 
2 :    How was the support you got from the staff while you were in the secluded  
        area ? 
 
Very                                                                                                              Very 
poor         -----------------------------------------------------------------------      good 
 
( Comments if you like ) : 
…………………………………………………………………………………………
………………………………………………………………………………………… 
 
 
 
3 :   How respectfully were you treated in general ? 
 
Very         -----------------------------------------------------------------------       Very                                          
disrespectfully                                                                                              respectfully 
 
( Comments if you like ) : 
…………………………………………………………………………………………
………………………………………………………………………………………… 
 
 
 
4 :   How pleased were you with the food in the secluded area ? 
 
Very                                                                                                           Very 
unpleased   -----------------------------------------------------------------------  pleased  
 
( Comments if you like ) : 
…………………………………………………………………………………………
…………………………………………………………………………………………. 
 
 
5 :  How did you find the interior of the side hall and your room ? 
 
Very                                                                                                            Very 
bad         -----------------------------------------------------------------------       good  
 
( Comments if you like ) : 
…………………………………………………………………………………………
………………………………………………………………………………………… 
 
 
 
 
 
  
 
 
 
6 :   Did the interior influence you in a positive or negative way? 
 
Very                                                                                                              Very 
negative    -----------------------------------------------------------------------      positive 
 
( Comments if you like ) : 
…………………………………………………………………………………………
………………………………………………………………………………………… 
 
 
 
7 :   How satisfying was the information given to you about effects and adverse  
       effects of the medication received while you were in the secluded area ? 
 
Very                                                                                                               Very 
dissatisfying  -----------------------------------------------------------------------   satisfying 
 
( Comments if you like ) : 
…………………………………………………………………………………………
………………………………………………………………………………………… 
 
 
 
8 :   How secure did you feel while you were staying in the secluded area ? 
 
Very                                                                                                                 Very 
insecure       -----------------------------------------------------------------------      secure 
 
 
 
 
 
 
 
                                                        Please make sure that you have answered all the 
eight questions with one cross on each line.  Put the questionnaire in the envelope and 
give it to the hospital staff.  Chief physician Gunnar Morken will handle the form. 
 
                                                       Thank you for your kind co-operation! 
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Appendix 5:    Therapeutic and control steps taken and nurses’ observations 
                                                 (Norwegian version). 
 
 
REGISTRERING  AV  PASIENTDATA  OG  TILTAK. 
        Prosjekt  ved  STPS  avdeling  Østmarka  post 1. 
 
Navn :                                    Nummer i studien :                   Registreringsdato : 
 
Punktene  1-23  registreres  for  de  siste  24  timer. 
Skjemaet fylles ut av miljøkontakt på ettermiddagsvakt ved tidspunkt for 
rapportskriving i cardex. 
 
nr Innhold Ikke 
tilstede 
Lite En god 
del 
Mye Svært 
mye 
1 Hyppighet av  
grenseutprøving.                 *
     
2 Intensitet av 
grenseutprøving.                 *
     
3 Behov for å sette  
grenser.                      * / **    
     
4 Mengde bruk av sosialt 
fellesareal.                          * 
     
5 Mengde bruk av TV /  
radio.                                  *   
     
6 Mengde bruk av aviser, 
blader og bøker.                 *   
     
7 Mengde besøk eller telefon  
fra/til familie og venner.   *    
     
8 Hvor mye er pasienten alene 
på sidegang/eget rom? 
     
9 Ekstrapyramidale 
bivirkninger utenom 
akathisi. 
     
10 Akathisi.      
 
*     Standard normalt for ikke pasienter. 
**   Hypotese om årsak:  …………………………………………………………… 
 
nr Innhold Brukt Ikke brukt 
11 Utgang uten følge   
12 Utgang med følge   
13 Fysiske tvangsmidler ( reimer)   
14 Dør til sidegang låst   
15 Fastvakt   
16 Formelt vedtak om restriksjon av 
besøk/telefon. 
  
 
 Medikamenter Brukt Preparat 
( navn) 
Dose Ikke 
brukt 
17 Sedativa og hypnotika     
18 Nevroleptika per os     
19 Nevroleptika inj. ekskl.depot     
20 Depotnevroleptika     
21 Antidepressiva     
22 Stemningsstabiliserende (antiepileptika og 
lithium) 
    
23 Antihistamin     
 
 
 
 
 
 
 
                                                                                     Utfylt av : 
Appendix VI

Appendix 6:  Therapeutic and control steps taken and nurses’ observations  
                                                   (English version). 
 
 
 
       Registration of patients, and therapeutic and control steps taken. 
           Project at St. Olavs Hospital, Dept. of Psychiatry, acute ward 1. 
 
Name :                                    Study ID :                   Date of registration : 
 
                The items 1-23  are registered for the last 24 hours. 
Each item is recorded by the primary nurse in the afternoon at the time of writing 
daily report in the cardex. 
 
nr Content Not 
present 
A little Some A lot Very 
much 
1 Frequency of                  
pushing limits.                  * 
     
2 Intensity of   
pushing limits.                  * 
     
3 Need to set  
limits.                         * / **    
     
4 Amount of used social            
and mutual areas.               * 
     
5 Use of   
TV / radio.                         *    
     
6 Use of papers, magazines 
and books.        *                     
     
7 Visits / telephones 
 from fam. / friends.          *    
     
8 Time alone in side-wing or 
patient room. 
     
9 Extrapyramidale side effects  
other than akathisia. 
     
10 Akathisia.      
 
*     Standard normal for persons not being patients. 
**   Hypothesis about reason.  
…………………………………………………………… 
 
nr Content Used Not used 
11 Going out without company   
12 Going out with company   
13 Restraints ( belts)   
14 Door to side-wing locked   
15 Continuous guard by nurses   
16 Formal restrictions in  
visits / telephone. 
  
 
 Medication Used Type 
( name) 
Doses Not 
used 
17 Sedatives and hypnotics     
18 Oral neuroleptics      
19 Inj. neuroleptics other than depots     
20 Depot neuroleptics     
21 Antidepressants     
22 Mood stabilisers (antiepileptic or lithium)     
23 Antihistamines     
 
 
 
 
 
 
 
                                                                                     Recorded by : 
Paper I
Paper I and II are not included in the file due to copyright.  
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Emergency Psychiatry
General Hospital Psyin the General Hospital
The emergency room is the interface between community and health care institution. Whether through outreach or in-hospital service, the
psychiatrist in the general hospital must have specialized skill and knowledge to attend the increased numbers of mentally ill, substance
abusers, homeless individuals, and those with greater acuity and comorbidity than previously known. This Special Section will address those
overlapping aspects of psychiatric, medicine, neurology, psychopharmacology, and psychology of essential interest to the psychiatrist who
provides emergency consultation and treatment to the general hospital population.
Substance abuse and recovery in a Psychiatric Intensive Care Unit
Arne E. Vaaler, M.D.T, Gunnar Morken, M.D., Ph.D., John Chr. Flbvig, M.D.,
Valentina C. Iversen, M.Phil., Olav M. Linaker, M.D., Ph.D.
Department of Neuroscience, Faculty of Medicine, Norwegian University of Science and Technology, N-7006 Trondheim, Norway
Department of Psychiatry, astmarka, St. Olavs University Hospital, N-7006 Trondheim, Norway
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Abstract
Objectives: The purpose of this study is to compare the development in symptoms, behaviors, function and treatment between patients with
or without a substance use (SU) diagnose in a Psychiatric Intensive Care Unit (PICU).
Methods: A total of 118 admitted patients were assessed at admittance, day 3 and discharge from the PICU. Symptoms of psychopathology,
therapeutic steps taken, violent episodes and length of patient stay were recorded.
Results:More males than females received an SU diagnosis. Substance use patients had less psychiatric symptoms at admittance and showed
a faster symptom reduction, more favorable and faster improvement of function and a shorter length of stay. Except for symptom reduction
and shorter length of stay, these differences were largely due to differences in sex and diagnoses in the two groups.
Conclusion: In a naturalistic group of patients in a PICU, SU is associated with favorable outcomes compared to patients not
using substances.
D 2006 Elsevier Inc. All rights reserved.
Keywords: Psychiatry; Emergency services; Intensive care; Substance abuse
chiatry 28 (2006) 65–701. Introduction
The frequency of psychoactive substance use (SU)
among psychiatric in-patients ranges from 25% to 75%
[1–3]. Substance use is associated with a variety of
adverse consequences [4]. There are indications that SU
patients present more severe symptomatology compared
to patients without substance use (WSU) [5]. Substance use
patients have been found to have higher rates of admissions
[6], greater use of in-patient services [7] and extensive social
dysfunction [8] compared to WSU patients. Substance use
has also been found to interfere with the expression and
resolution of symptoms of psychiatric disorders [9] to
dramatically induce or influence acute behavioral changes
and to have significant effects on treatment outcome and
costs [10,11].0163-8343/$ – see front matter D 2006 Elsevier Inc. All rights reserved.
doi:10.1016/j.genhosppsych.2005.08.009
T Corresponding author. astmarka Psychiatric Department, St. Olavs
Hospital, Box 3008 Lade, N-7441 Trondheim, Norway. Tel.: +47
73864500, +47 73864902; fax: +47 73864902.
E-mail address: arne.e.vaaler@ntnu.no (A.E. Vaaler).There are indications that SU psychiatric in-patients have
different recoveries and needs compared to not active users
[2]. Bowers et al. [12] used fixed doses of neuroleptics
comparing effects in psychotic in-patients who were users or
not users of substances. They found a relative neuroleptic
refractoriness in the SU group. Sanguineti and Samuel [13]
compared acutely admitted in-patients screened positive for
SU with patients screened negative for SU. At day 5, patients
with schizophrenia and SU had lower BPRS scores than
those with schizophrenia and negative screens [14]. These
findings were taken as an indication of greater recovery from
psychotic relapse in the SU group. In the same study, a
reverse trend was found among patients with affective
disorders. Goldberg et al. [15] found SU among bipolar
1 in-patients to be associated with slower symptom reduction
and lower likelihood of remission from a manic episode.
Ries et al. [16] used the Psychiatric Symptom Assess-
ment Form [17] demonstrating that SU in-patients with
acute schizophrenia admitted to integrated treatment for
psychiatric and addiction disorders had a greater treatment
A.E. Vaaler et al. / General Hospital Psychiatry 28 (2006) 65–7066response than WSU patients receiving similar services, but
without the drug and alcohol focus. In this integrated
treatment program, the SU patients had 30% shorter length
of stay compared to WSU patients [16]. Substance use
predicting shorter length of stay has been found in other
studies [18–20], but not in all [21].
In Psychiatric Intensive Care Units (PICUs) and emer-
gency services, SU patients constitute a very heterogeneous
patient group, spanning from patients with independent
mental disorders complicated by SU to patients with
psychoactive SU-induced disorders only [3]. The typical
contemporary PICU patient presents in severe crisis often
complicated by SU, behavioral dyscontrol and multiple axis
1 diagnoses [11].
Studies of SU conducted in PICU populations are sparse.
In these acute settings, time is an essential factor. Patient
observations and admissions are brief. Recent research have
shown that SU patients in other in-patient settings benefit
from integrated treatments, as opposed to treatments
available in ordinary psychiatric or SU treatment facilities
[16,22]. Investigations of clinical differences between SU
and WSU patients in PICUs are important in order to
develop integrated treatments for the SU populations in
acute units.
The aims of the present study were to investigate
differences in symptoms, behaviors, therapeutic steps taken
and length of stay in a PICU between patients with SU or
WSU diagnosis.2. Methods
2.1. Population
The acute astmarka Psychiatric Department, St. Olavs
University Hospital, Trondheim, Norway, has a catchment
area of 140000 inhabitants both from the city of Trondheim
(50%) and the surrounding rural areas (50%). About 600
adult patients suffering from acute psychiatric conditions are
admitted each year. All persons in the catchment area in need
of PICU are admitted to this department. Only patients with
acute psychiatric conditions are admitted to the department.
Patients with intoxication alone are admitted to separate
acute, short-term substance abuse treatment facilities.
2.2. Setting
The acute department consists of two ordinary closed
ward areas, each with a PICU area with four beds. The
patients were admitted to the acute ward with most free
capacity. One ward was used for the study, and the patients
excluded from the study were admitted to the other ward.
The study changed as little as possible of the daily routines
of the department.
The physician on duty evaluated all the patients acutely
admitted to the ward. The patients evaluated to be in need of
PICU were admitted to the PICU area and included in the
study, except patients with dementia, mental retardation orautism to a severe degree and patients not speaking
Norwegian or English. These patients were excluded at
evaluation before entering the PICU area and admitted to
the other ward.
2.3. Instruments
Symptoms, general psychopathology, function and be-
havior were assessed with the Positive And Negative
Syndrome Scale (PANSS) for schizophrenia [23], with time
criterion the last 24 h, the Global Assessment Scale Split
version (GAF-S) and the Broset Violence Checklist (BVC)
[24] at admittance (baseline), day 3 and at discharge (end
point) from PICU. Global Assessment Scale Split version is
based on DSM-4’s GAF [25] and is a two-item scale
measuring global symptoms (GAF-S-Symptoms) and func-
tioning (GAF-S-Function) separately. Broset Violence
Checklist is a six-item observer-rated scale scoring behav-
iors that predict imminent violence in psychiatric inpatients
[26]. Violent or threatening incidents were recorded with
Staff Observation Aggression Scale-Revised [27]. Thera-
peutic and control steps were taken and nurses’ observations
were coded daily on a 23-item checklist. These therapeutic
steps and observations included for instance all prescribed
medication, side effects, formal restrictions, staff contact
time, use of newspapers and visits from relatives. Specially
trained unit nurses did all the ratings. At admittance, the
physician on duty evaluated the patients’ need for PICU on
a scale with scorings 1– 4 (4 representing absolute need).
The reasons for admittance to PICU were rated on a scale
with four categories (patient’s own wish, need of close
observation, stimuli reduction or control of behavior).
The decision to transfer a patient from PICU to ordinary
area was a joint decision in the ward staff after taking into
account symptoms, behavior and function. The day the
patients were transferred to the ordinary area of the ward
were recorded as end point of the study.
The patients were systematically examined for SU at
admittance, in evaluation with ward psychiatrist the first
weekday after admittance and at discharge from PICU. The
families and general practitioners of many of the patients
were also questioned about SU. In the first period
(November 13, 2000, to March 25, 2001) (n=56), urine
samples were analyzed on clinical suspicion of SU. In the
second period (October 1, 2001, to March 21, 2002) (n=62),
all admitted patients had urine and blood samples taken
within a few hours of admission. The urine samples were
analyzed with liquid chromatography with mass spectrom-
etry. In cases with positive urine samples, quantification of
the same substances in blood was done.
The reports from the laboratory were available a week
after admittance, and the clinicians were not aware of the
results from the analysis in the acute treatment period.
Diagnoses according to ICD-10 Diagnostic criteria for
research [28] were set by consensus in the department’s
staff, including at least three specialists in psychiatry of
whom at least two personally knew the patient.
Table 2
The changes in assessments of behavior, function and symptoms from
baseline to day 3 or in end point stays shorter than 3 days among patients
with an SU and WSU diagnosis
Characteristic SU group (n =43) WSU group (n =75) P
Mean S.D. Mean S.D.
PANSS total 5.0 11.3 1.9 18.4 ns
PANSS positive 1.2 4.7 1.5 5.8 ns
PANSS negative 0.8 3.5 0.0 5.2 ns
PANSS general 2.9 6.8 0.9 10.1 ns
BVC 0.40 0.91 0.32 1.25 ns
GAF-S-Function 4.9 9.7 1.4 8.3 ns
GAF-S-Symptoms 11.0 14.5 2.0 9.3 .002
Length of stay in days 2.86 2.89 7.08 7.70 .011
Length of stay in psychiatric intensive care (Mann–Whitney U tests).
Negative values due to lower scorings at day 3.
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discharged from the hospital, and the results from all
analyses for SU were taken into account. The patients filling
criteria for any SU disorder (F10.00–F19.99) were allocated
to the SU group regardless of other diagnoses. Patients not
filling criteria for any SU disorder constituted the WSU
group.
2.4. Study design
The study is a descriptive longitudinal study with con-
trol group.
2.5. Statistics
Differences between the SU and the WSU groups were
assessed by Student’s t test and Mann–Whitney U test (two-
tailed). v2 was used to compare frequencies. Missing values
for single items on the rating scales were substituted by the
mean for the item. We used post hoc regression analyses to
assess the influence of differences in sex ratio and the
presence of affective or schizophrenic disorder on the
differences between the groups.
2.6. Ethics
The study was approved by bThe Regional Medical
Research Ethics Committee, Central Norway.QTable 3
Significant differences in daily assessments on the 23-item checklist
btherapeutic and control steps taken and nurses’ observationsQ (first 3 days)3. Results
A total of 43 (SU group) and 75 (WSU group) patients
were included. More males (36 of 67) than females (7 of 51)
were substance users (v2=20.01, df=1, PV.0001). There
were no differences in mean age between SU [37.8 (S.D.,
14.3)] and WSU [35.6 (S.D., 15.5)]. One patient with senile
dementia was excluded. There were a tendency toward
differences in the reasons for stay in PICU with more
patients in SU group admitted with reason bto control the
patients behaviorQ (v2=8.19, df=4, P=.08). When corrected
for sex ratio and diagnostic composition, the differenceTable 1
Assessments of behavior, function and symptoms at baseline of patients
with an SU diagnosis and without a substance use diagnosis (WSU)
Characteristic SU group (n =43) WSU group (n =75) P
Mean S.D. Mean S.D.
PANSS totala 68.6 21.5 77.0 22.2 .02
PANSS positiveb 15.5 7.6 19.0 8.2 .02
PANSS negativeb 16.6 8.1 18.6 8.3 ns
PANSS generalc 36.5 9.0 39.5 10.2 ns
BVCd 0.88 1.19 0.78 1.21 ns
GAF-S-Functione 33.8 12.1 32.0 12.8 ns
GAF-S-Symptomse 32.1 12.8 31.6 13.0 ns
Mann–Whitney U tests.
a Scoring range, 30–210.
b Scoring range, 7–49.
c Scoring range, 16–112.
d Scoring range, 0–6.
e Scoring range, 1–100.became significant (P=.002). Data for behavior, function
and symptoms at admittance are summarized in Table 1.
There were significant group differences in PANSS-positive
subscales and PANSS total indicating more psychiatric
symptoms in the WSU group. There were significant
differences in single items concerning delusions, conceptual
disorganization and suspiciousness. These differences,
however, turned out to be dependent upon sex and
diagnoses. The changes in assessments of behavior, function
and symptoms from baseline (admittance) to day 3, and
length of stay in PICU are summarized in Table 2. There
was a significant difference in the changes of the GAF-S-
Symptoms ratings with largest increase in the SU group
indicating more reduction of symptoms. This remained
significant after correction for sex and diagnoses (P=.002).
Length of stay was significantly shorter in the SU group
with means 2.86 and 7.08. After correction for sex and
diagnoses, this remained significantly different (P=.014).
There were 6 (SU) and 13 (WSU) violent or threatening
incidents with no significant difference between groups.between patients with an SU and WSU diagnosis
Characteristic SU group
(n =85 days)
WSU group
(n =174 days)
P
Mean S.D. Mean S.D.
Frequency of testing out and
pushing limitsa
0.40 0.85 0.63 0.95 .025
Intensity of testing out and
pushing limitsa
0.48 0.80 0.71 1.04 .031
Adequate use of TV/radioa 0.96 0.99 0.67 0.85 .022
Adequate use of papers,
magazines and booksa
0.88 0.97 0.64 0.85 .043
Amount of visits and telephones
from family and friendsa
0.78 0.79 1.10 0.92 .007
Antidepressantsb 0.22 0.42 0.13 0.33 .045
Neurolepticsb 0.27 0.45 0.47 0.50 .002
Mann–Whitney U tests.
a Five category scale: 0=not present, 1=minimal, 2=some, 3=much,
4=very much.
b Two category scale: 0=not used, 1=used.
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steps taken and nurses’ observations were significantly
different between groups assessed daily the first 3 days. The
main differences are summarized in Table 3. Generally, the
SU group tended to have a behavior less associated with
pushing and testing out limits, a more adequate use of TV,
radio and newspapers, and to use less per oral neuroleptics
and more antidepressants compared to the WSU group.
These effects were, however, largely explained by group
differences in sex ratio and diagnoses. The WSU group had
more visits and telephones from family and friends.4. Discussion
We have studied a naturalistic sample of consecutively,
acutely admitted in-patients in need of PICU. Patients with
an SU diagnosis showed a faster symptom reduction, a more
favorable and faster improvement of function and a shorter
length of stay in PICU compared to patients without an SU
diagnosis. Drake et al. [4] concluded that SU among
psychiatric patients are associated with a variety of adverse
consequences. Our data indicate that SU in PICU popula-
tions are associated with favorable treatment outcomes
compared to WSU patients for the present admission.
The present study demonstrates a male dominance
among SU patients. Ries et al. [16] found 65% males in a
population of acutely admitted schizophrenic in-patients.
Sanguineti and Samuel [13] found no gender difference in
a population of patients with exacerbation of long-
standing disorders.
The results from previous research, mostly derived from
outpatient populations, indicate that SU patients present
more severe symptomatology compared to WSU patients
[2,5,29]. In the present study from a PICU population,
both total PANSS scores and PANSS-positive subscale,
including delusions, conceptual disorganization and suspi-
ciousness, were lower among SU patients than WSU
patients at baseline. Even if these differences turned out to
be dependent upon sex and diagnoses, our data do not
indicate that SU populations in this setting present more
severe symptomatology.
The differences in the number of btherapeutic steps taken
and nurses’ observationsQ indicate that the improvement in
function of the SU group was greater than in the WSU
group. The degree of testing out limits and adequate use of
social areas, papers, TV and radio was all in favor of the SU
group indicating better function. A similar indication is the
lower use of neuroleptics and higher use of antidepressants
in the SU group.
The patients in the SU group had greater symptom
reduction with more increase in GAF-S-Symptoms measured
from admittance to day 3. Sanguineti and Samuel [13] have
demonstrated similar findings among patients with schizo-
phrenia but not among patients with affective disorders.
The findings in previous studies indicating that SU is
associated with hostility and assaultiveness [4] were notsupported by our data. The results from therapeutic steps
taken and nurses’ observations were significantly in favor of
the SU patients indicating behavior less associated with
hostility and assaultiveness, and if corrected for sex and
diagnoses, no group differences were found, although the
tendency remained. The differences between studies
concerning hostility and assaultiveness are probably due to
different populations. Drake et al. mostly refer to outpatient
populations. Our findings are similar to Dhossche’s [30].
His data were drawn from an emergency patient population
in a locked, short-term (up to 72 h) holding area for
extended evaluations. The main findings of the study were
that aggression is not a common acute manifestation of
recent SU in psychiatric emergency room patients.
Patients in the SU group had a length of stay in PICU at
only 40% of the WSU group’s. The trends in these findings
are underscored by the findings in therapeutic steps taken
and nurses’ observations. Even though the SU group had a
nonsignificantly increased frequency of need to stay in
PICU due to behavioral reasons at admittance, the patients
in this group displayed significantly less testing out
behavior and significantly more behavior associated with
ability to and interest in social activities the first 3 days, a
trend that remained after correction for sex and diagnoses.
These factors were obviously important in the joint staff
decision to discharge patients from PICU. The rapid
improvement was not associated with increased support
from family and friends because we found more visits and
telephones to patients in the WSU group.
The significantly different use of neuroleptics and
antidepressants between groups could indicate different
degrees of depressive symptoms or side-effects influencing
function and symptoms. This was not supported by our data.
The PANSS general psychopathology item bglobal
depressionQ was identical in the groups both at admittance
and after 3 days. Daily registrations of potential side effects
including dystonias and akathisia were similar in the groups.
Differences in the patient populations included in the
studies, variations in institutional routines between hospitals
and differences in design limit the possibility to generalize
results from studies in acute psychiatric departments. In the
present study, all consecutively admitted patients from a
defined catchment area were included. The use of stan-
dardized instruments to assess behavior, function and
symptoms at admittance and day 3, together with daily
thorough registration of therapeutic and control steps taken
and nurses’ observations, made it possible to evaluate
changes with acceptable control of most important factors
affecting treatment.
Many studies have found a low detection rate of SU in
psychiatric treatment [2]. In our study, the investigation of
SU was extensive. There is a reason to believe that the
number of undetected SU patients is limited. In the first
period of the data collection, urine and blood samples were
not collected from every patient; still, the fraction with SU
patients did not differ between the two periods.
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patients with an SU disorder without taking into account
whether they had other axis 1 diagnoses or not. The SU group
patients are thus composed of patients with both independent
mental disorders complicated by SU and patients with
psychoactive SU-induced disorders only. Distinctions be-
tween these two groups are difficult in a short-term setting.
Although we have attempted to correct our main findings for
comorbidity of affective disorders and schizophrenia, some
caution is warranted in comparing our results with other
studies using different diagnostic definitions.
The empirical evidence from other inpatient and outpa-
tient samples strongly supports the adverse effects of
substance abuse on the course of severe mental illnesses.
Long-time consequences are symptom exacerbation, in-
creased hospitalization, medication noncompliance, disrup-
tive behavior and decreased social functioning [31].
Findings from acute and PICU populations are different
with shorter lengths of stay and improved outcomes in SU
groups compared to WSU groups. These findings have been
explained by premature discharges of SU patients [22]. Our
study does not support this. There is a reason to believe that
shorter lengths of stay in acute settings is partially due to a
higher proportion of patients with psychoactive SU-induced
disorders in the acute settings compared to other inpatient or
outpatient settings. However, Ries et al. [16] had similar
results from a study in acute settings in a sample of patients
with schizophrenia and SU compared to schizophrenia and
WSU. We believe that these findings are due to induction or
amplification of symptoms by SU in the SU group. Such
symptoms may normalize rapidly after removal of abused
substances, which would account for their shorter stays and
improved outcomes.
Recent research has shown that psychiatric patients with
SU and a psychiatric disorder benefit more from a specially
integrated treatment compared to treatment in psychiatric or
SU treatment facilities [22,32,33]. Randomized controlled
clinical trials evaluating effects of integrated treatments in
PICU populations are lacking. However, there is a reason to
believe that patients in PICU populations also would benefit
from integrated treatments. A study from two PICUs and
nine open acute wards in inner London indicates the
frequency of SU in PICUs [34]. Eighty-nine percent of
the patients reported to have had used illicit drugs or
alcohol on the ward during a previous admission, and 83%
had used substances during the current admission. The
clinical implication of this is an obvious need of routine
screening for nonprescribed psychoactive drugs.
There is also a reason to believe that the staffs in PICUs
need increased attention to SU. In a study by Prochaska
et al. [35], it was demonstrated that increased attention to
SU has consequences for assessments, discharge diagnoses
and treatment planning, including referrals to SU treatment.
The SU group in our study had a mean length of stay of
2.86 days. Additional interventions during stay for this
patient group have to be of short duration. Of special interestis, therefore, the study of Swanson et al., indicating that the
addition of a brief intervention (1 h and 15 min) based on
motivational interviewing to an already intensive inpatient
program led to a better treatment adherence among dually
diagnosed inpatients.5. Conclusion
In a naturalistic group of patients admitted to PICU, SU
is associated with faster improvement, more favorable
behavior and shorter length of stay in intensive treatment
compared to WSU patients.Acknowledgment
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Abstract: 
Objectives: The aims of the present study were to investigate possible 
predictive factors for threats and violent incidents the first three days in a 
PICU population based on evaluations done at admittance. 
Methods: In 2000 and 2001 a total of 118 consecutive patients were assessed 
at admittance to a PICU. Actuarial data from present admission, global clinical 
evaluations by physician and clinical nurses first day, and environmental 
factors were related to the outcome measure Staff Observation Aggression 
Scale-Revised (SOAS-R). Hierarchical multiple linear regression analyses 
were performed to determine the factors that best predicted SOAS-R 
incidents. 
Results:  The final hierarchical regression analysis gave an R = .59, F (2, 106) 
= 5.17, p< .001. The global clinical evaluations and an observer scale scoring 
behaviours that predict short-term violence in psychiatric inpatients (The 
Broset Violence Checklist) were effective and more suitable than actuarial 
data in predicting short-term aggression. Environmental factors like 
segregation of patients in the PICU were important. 
Conclusion: In a naturalistic group of patients in a PICU prediction of 
aggressive and threatening incidents should be based on clinical global 
judgement, and instruments designed to predict short-term aggression in 
psychiatric inpatients.  
 
                                                                             
 
Dissertations at the Faculty of Medicine, NTNU 
 
1977 
1. Knut Joachim Berg: EFFECT OF ACETYLSALICYLIC ACID ON RENAL FUNCTION 
2. Karl Erik Viken and Arne Ødegaard: STUDIES ON HUMAN MONOCYTES CULTURED IN  
VITRO 
1978 
3. Karel Bjørn Cyvin: CONGENITAL DISLOCATION OF THE HIP JOINT. 
4. Alf O. Brubakk: METHODS FOR STUDYING FLOW DYNAMICS IN THE LEFT 
VENTRICLE  AND THE AORTA IN MAN. 
1979 
5. Geirmund Unsgaard: CYTOSTATIC AND IMMUNOREGULATORY ABILITIES OF HUMAN    
BLOOD MONOCYTES CULTURED IN VITRO 
1980 
6. Størker Jørstad: URAEMIC TOXINS 
7. Arne Olav Jenssen: SOME RHEOLOGICAL, CHEMICAL AND STRUCTURAL PROPERTIES    
OF MUCOID SPUTUM FROM PATIENTS WITH CHRONIC OBSTRUCTIVE BRONCHITIS 
1981 
8. Jens Hammerstrøm: CYTOSTATIC AND CYTOLYTIC ACTIVITY OF HUMAN 
MONOCYTES AND EFFUSION MACROPHAGES AGAINST TUMOR CELLS IN VITRO 
1983 
9. Tore Syversen: EFFECTS OF METHYLMERCURY ON RAT BRAIN PROTEIN. 
10. Torbjørn Iversen: SQUAMOUS CELL CARCINOMA OF THE VULVA. 
1984 
11. Tor-Erik Widerøe: ASPECTS OF CONTINUOUS AMBULATORY PERITONEAL DIALYSIS. 
12. Anton Hole: ALTERATIONS OF MONOCYTE AND LYMPHOCYTE FUNCTIONS IN 
REALTION TO SURGERY UNDER EPIDURAL OR GENERAL ANAESTHESIA. 
13. Terje Terjesen: FRACTURE HEALING AN STRESS-PROTECTION AFTER METAL PLATE 
FIXATION AND EXTERNAL FIXATION. 
14. Carsten Saunte: CLUSTER HEADACHE SYNDROME. 
15. Inggard Lereim: TRAFFIC ACCIDENTS AND THEIR CONSEQUENCES. 
16. Bjørn Magne Eggen: STUDIES IN CYTOTOXICITY IN HUMAN ADHERENT 
MONONUCLEAR BLOOD CELLS. 
17. Trond Haug: FACTORS REGULATING BEHAVIORAL EFFECTS OG DRUGS. 
1985 
18. Sven Erik Gisvold: RESUSCITATION AFTER COMPLETE GLOBAL BRAIN ISCHEMIA. 
19. Terje Espevik: THE CYTOSKELETON OF HUMAN MONOCYTES. 
20. Lars Bevanger: STUDIES OF THE Ibc (c) PROTEIN ANTIGENS OF GROUP B 
STREPTOCOCCI. 
21. Ole-Jan Iversen: RETROVIRUS-LIKE PARTICLES IN THE PATHOGENESIS OF PSORIASIS. 
22. Lasse Eriksen: EVALUATION AND TREATMENT OF ALCOHOL DEPENDENT 
BEHAVIOUR. 
23. Per I. Lundmo: ANDROGEN METABOLISM IN THE PROSTATE. 
1986 
24. Dagfinn Berntzen: ANALYSIS AND MANAGEMENT OF EXPERIMENTAL AND CLINICAL 
PAIN. 
25. Odd Arnold Kildahl-Andersen: PRODUCTION AND CHARACTERIZATION OF 
MONOCYTE-DERIVED CYTOTOXIN AND ITS ROLE IN MONOCYTE-MEDIATED 
CYTOTOXICITY. 
26. Ola Dale: VOLATILE ANAESTHETICS. 
1987 
27. Per Martin Kleveland: STUDIES ON GASTRIN. 
28. Audun N. Øksendal: THE CALCIUM PARADOX AND THE HEART. 
29. Vilhjalmur R. Finsen: HIP FRACTURES 
1988 
30. Rigmor Austgulen: TUMOR NECROSIS FACTOR: A MONOCYTE-DERIVED REGULATOR 
OF CELLULAR GROWTH. 
31. Tom-Harald Edna: HEAD INJURIES ADMITTED TO HOSPITAL. 
32. Joseph D. Borsi: NEW ASPECTS OF THE CLINICAL PHARMACOKINETICS OF 
METHOTREXATE. 
33. Olav F. M. Sellevold: GLUCOCORTICOIDS IN MYOCARDIAL PROTECTION. 
34. Terje Skjærpe: NONINVASIVE QUANTITATION OF GLOBAL PARAMETERS ON LEFT 
VENTRICULAR FUNCTION: THE SYSTOLIC PULMONARY ARTERY PRESSURE AND 
CARDIAC OUTPUT. 
35. Eyvind Rødahl: STUDIES OF IMMUNE COMPLEXES AND RETROVIRUS-LIKE ANTIGENS 
IN PATIENTS WITH ANKYLOSING SPONDYLITIS. 
36. Ketil Thorstensen: STUDIES ON THE MECHANISMS OF CELLULAR UPTAKE OF IRON 
FROM TRANSFERRIN. 
37. Anna Midelfart: STUDIES OF THE MECHANISMS OF ION AND FLUID TRANSPORT IN 
THE BOVINE CORNEA. 
38. Eirik Helseth: GROWTH AND PLASMINOGEN ACTIVATOR ACTIVITY OF HUMAN 
GLIOMAS AND BRAIN METASTASES - WITH SPECIAL REFERENCE TO 
TRANSFORMING GROWTH FACTOR BETA AND THE EPIDERMAL GROWTH FACTOR 
RECEPTOR. 
39. Petter C. Borchgrevink: MAGNESIUM AND THE ISCHEMIC HEART. 
40. Kjell-Arne Rein: THE EFFECT OF EXTRACORPOREAL CIRCULATION ON 
SUBCUTANEOUS TRANSCAPILLARY FLUID BALANCE. 
41. Arne Kristian Sandvik: RAT GASTRIC HISTAMINE. 
42. Carl Bredo Dahl: ANIMAL MODELS IN PSYCHIATRY. 
1989 
43. Torbjørn A. Fredriksen: CERVICOGENIC HEADACHE. 
44. Rolf A. Walstad: CEFTAZIDIME. 
45. Rolf Salvesen: THE PUPIL IN CLUSTER HEADACHE. 
46. Nils Petter Jørgensen: DRUG EXPOSURE IN EARLY PREGNANCY. 
47. Johan C. Ræder: PREMEDICATION AND GENERAL ANAESTHESIA IN OUTPATIENT 
GYNECOLOGICAL SURGERY. 
48. M. R. Shalaby: IMMUNOREGULATORY PROPERTIES OF TNF-α AND THE RELATED 
CYTOKINES. 
49. Anders Waage: THE COMPLEX PATTERN OF CYTOKINES IN SEPTIC SHOCK. 
50. Bjarne Christian Eriksen: ELECTROSTIMULATION OF THE PELVIC FLOOR IN FEMALE 
URINARY INCONTINENCE. 
51. Tore B. Halvorsen: PROGNOSTIC FACTORS IN COLORECTAL CANCER. 
1990 
52. Asbjørn Nordby: CELLULAR TOXICITY OF ROENTGEN CONTRAST MEDIA. 
53. Kåre E. Tvedt: X-RAY MICROANALYSIS OF BIOLOGICAL MATERIAL. 
54. Tore C. Stiles: COGNITIVE VULNERABILITY FACTORS IN THE DEVELOPMENT AND 
MAINTENANCE OF DEPRESSION. 
55. Eva Hofsli: TUMOR NECROSIS FACTOR AND MULTIDRUG RESISTANCE. 
56. Helge S. Haarstad: TROPHIC EFFECTS OF CHOLECYSTOKININ AND SECRETIN ON THE 
RAT PANCREAS. 
57. Lars Engebretsen: TREATMENT OF ACUTE ANTERIOR CRUCIATE LIGAMENT INJURIES. 
58. Tarjei Rygnestad: DELIBERATE SELF-POISONING IN TRONDHEIM. 
59. Arne Z. Henriksen: STUDIES ON CONSERVED ANTIGENIC DOMAINS ON MAJOR OUTER 
MEMBRANE PROTEINS FROM ENTEROBACTERIA. 
60. Steinar Westin: UNEMPLOYMENT AND HEALTH: Medical and social consequences of a 
factory closure in a ten-year controlled follow-up study. 
61. Ylva Sahlin: INJURY REGISTRATION, a tool for accident preventive work. 
62. Helge Bjørnstad Pettersen: BIOSYNTHESIS OF COMPLEMENT BY HUMAN ALVEOLAR 
MACROPHAGES WITH SPECIAL REFERENCE TO SARCOIDOSIS. 
63. Berit Schei: TRAPPED IN PAINFUL LOVE. 
64. Lars J. Vatten: PROSPECTIVE STUDIES OF THE RISK OF BREAST CANCER IN A 
COHORT OF NORWEGIAN WOMAN. 
1991 
65. Kåre Bergh: APPLICATIONS OF ANTI-C5a SPECIFIC MONOCLONAL ANTIBODIES FOR 
THE ASSESSMENT OF COMPLEMENT ACTIVATION. 
66. Svein Svenningsen: THE CLINICAL SIGNIFICANCE OF INCREASED FEMORAL 
ANTEVERSION. 
67. Olbjørn Klepp: NONSEMINOMATOUS GERM CELL TESTIS CANCER: THERAPEUTIC 
OUTCOME AND PROGNOSTIC FACTORS. 
109. Arild Faxvaag: STUDIES OF IMMUNE CELL FUNCTION in mice infected with MURINE 
RETROVIRUS. 
1996 
110. Svend Aakhus: NONINVASIVE COMPUTERIZED ASSESSMENT OF LEFT VENTRICULAR 
FUNCTION AND SYSTEMIC ARTERIAL PROPERTIES. Methodology and some clinical 
applications. 
111. Klaus-Dieter Bolz: INTRAVASCULAR ULTRASONOGRAPHY. 
112. Petter Aadahl: CARDIOVASCULAR EFFECTS OF THORACIC AORTIC CROSS-
CLAMPING. 
113. Sigurd Steinshamn: CYTOKINE MEDIATORS DURING GRANULOCYTOPENIC 
INFECTIONS. 
114. Hans Stifoss-Hanssen: SEEKING MEANING OR HAPPINESS? 
115. Anne Kvikstad: LIFE CHANGE EVENTS AND MARITAL STATUS IN RELATION TO RISK 
AND PROGNOSIS OF CANSER. 
116. Torbjørn Grøntvedt: TREATMENT OF ACUTE AND CHRONIC ANTERIOR CRUCIATE 
LIGAMENT INJURIES. A clinical and biomechanical study. 
117. Sigrid Hørven Wigers: CLINICAL STUDIES OF FIBROMYALGIA WITH FOCUS ON 
ETIOLOGY, TREATMENT AND OUTCOME. 
118. Jan Schjøtt: MYOCARDIAL PROTECTION: Functional and Metabolic Characteristics of Two 
Endogenous Protective Principles. 
119. Marit Martinussen: STUDIES OF INTESTINAL BLOOD FLOW AND ITS RELATION TO 
TRANSITIONAL CIRCULATORY ADAPATION IN NEWBORN INFANTS. 
120. Tomm B. Müller: MAGNETIC RESONANCE IMAGING IN FOCAL CEREBRAL ISCHEMIA. 
121. Rune Haaverstad: OEDEMA FORMATION OF THE LOWER EXTREMITIES. 
122. Magne Børset: THE ROLE OF CYTOKINES IN MULTIPLE MYELOMA, WITH SPECIAL 
REFERENCE TO HEPATOCYTE GROWTH FACTOR. 
123. Geir Smedslund: A THEORETICAL AND EMPIRICAL INVESTIGATION OF SMOKING, 
STRESS AND DISEASE: RESULTS FROM A POPULATION SURVEY. 
1997 
124. Torstein Vik: GROWTH, MORBIDITY, AND PSYCHOMOTOR DEVELOPMENT IN 
INFANTS WHO WERE GROWTH RETARDED IN UTERO. 
125. Siri Forsmo: ASPECTS AND CONSEQUENCES OF OPPORTUNISTIC SCREENING FOR 
CERVICAL CANCER. Results based on data from three Norwegian counties. 
126. Jon S. Skranes: CEREBRAL MRI AND NEURODEVELOPMENTAL OUTCOME IN VERY 
LOW BIRTH WEIGHT (VLBW) CHILDREN. A follow-up study of a geographically based year 
cohort of VLBW children at ages one and six years. 
127. Knut Bjørnstad: COMPUTERIZED ECHOCARDIOGRAPHY FOR EVALUTION OF 
CORONARY ARTERY DISEASE. 
128. Grethe Elisabeth Borchgrevink: DIAGNOSIS AND TREATMENT OF WHIPLASH/NECK 
SPRAIN INJURIES CAUSED BY CAR ACCIDENTS. 
129. Tor Elsås: NEUROPEPTIDES AND NITRIC OXIDE SYNTHASE IN OCULAR AUTONOMIC 
AND SENSORY NERVES. 
130. Rolf W. Gråwe: EPIDEMIOLOGICAL AND NEUROPSYCHOLOGICAL PERSPECTIVES ON 
SCHIZOPHRENIA. 
131. Tonje Strømholm: CEREBRAL HAEMODYNAMICS DURING THORACIC AORTIC 
CROSSCLAMPING. An experimental study in pigs. 
1998 
132. Martinus Bråten: STUDIES ON SOME PROBLEMS REALTED TO INTRAMEDULLARY 
NAILING OF FEMORAL FRACTURES. 
133. Ståle Nordgård: PROLIFERATIVE ACTIVITY AND DNA CONTENT AS PROGNOSTIC 
INDICATORS IN ADENOID CYSTIC CARCINOMA OF THE HEAD AND NECK. 
134. Egil Lien: SOLUBLE RECEPTORS FOR TNF AND LPS: RELEASE PATTERN AND 
POSSIBLE SIGNIFICANCE IN DISEASE. 
135. Marit Bjørgaas: HYPOGLYCAEMIA IN CHILDREN WITH DIABETES MELLITUS 
136. Frank Skorpen: GENETIC AND FUNCTIONAL ANALYSES OF DNA REPAIR IN HUMAN 
CELLS. 
137. Juan A. Pareja: SUNCT SYNDROME. ON THE CLINICAL PICTURE. ITS DISTINCTION 
FROM OTHER, SIMILAR HEADACHES. 
138. Anders Angelsen: NEUROENDOCRINE CELLS IN HUMAN PROSTATIC CARCINOMAS 
AND THE PROSTATIC COMPLEX OF RAT, GUINEA PIG, CAT AND DOG. 
68. Trond Sand: THE EFFECTS OF CLICK POLARITY ON BRAINSTEM AUDITORY EVOKED 
POTENTIALS AMPLITUDE, DISPERSION, AND LATENCY VARIABLES. 
69. Kjetil B. Åsbakk: STUDIES OF A PROTEIN FROM PSORIATIC SCALE, PSO P27, WITH 
RESPECT TO ITS POTENTIAL ROLE IN IMMUNE REACTIONS IN PSORIASIS. 
70. Arnulf Hestnes: STUDIES ON DOWN´S SYNDROME. 
71. Randi Nygaard: LONG-TERM SURVIVAL IN CHILDHOOD LEUKEMIA. 
72. Bjørn Hagen: THIO-TEPA. 
73. Svein Anda: EVALUATION OF THE HIP JOINT BY COMPUTED TOMOGRAMPHY AND 
ULTRASONOGRAPHY. 
1992 
74. Martin Svartberg: AN INVESTIGATION OF PROCESS AND OUTCOME OF SHORT-TERM 
PSYCHODYNAMIC PSYCHOTHERAPY. 
75. Stig Arild Slørdahl: AORTIC REGURGITATION. 
76. Harold C Sexton: STUDIES RELATING TO THE TREATMENT OF SYMPTOMATIC NON-
PSYCHOTIC PATIENTS. 
77. Maurice B. Vincent: VASOACTIVE PEPTIDES IN THE OCULAR/FOREHEAD AREA. 
78. Terje Johannessen: CONTROLLED TRIALS IN SINGLE SUBJECTS. 
79. Turid Nilsen: PYROPHOSPHATE IN HEPATOCYTE IRON METABOLISM. 
80. Olav Haraldseth: NMR SPECTROSCOPY OF CEREBRAL ISCHEMIA AND REPERFUSION 
IN RAT. 
81. Eiliv Brenna: REGULATION OF FUNCTION AND GROWTH OF THE OXYNTIC MUCOSA. 
1993 
82. Gunnar Bovim: CERVICOGENIC HEADACHE. 
83. Jarl Arne Kahn: ASSISTED PROCREATION. 
84. Bjørn Naume: IMMUNOREGULATORY EFFECTS OF CYTOKINES ON NK CELLS. 
85. Rune Wiseth: AORTIC VALVE REPLACEMENT. 
86. Jie Ming Shen: BLOOD FLOW VELOCITY AND RESPIRATORY STUDIES. 
87. Piotr Kruszewski: SUNCT SYNDROME WITH SPECIAL REFERENCE TO THE 
AUTONOMIC NERVOUS SYSTEM. 
88. Mette Haase Moen: ENDOMETRIOSIS. 
89. Anne Vik: VASCULAR GAS EMBOLISM DURING AIR INFUSION AND AFTER 
DECOMPRESSION IN PIGS. 
90. Lars Jacob Stovner: THE CHIARI TYPE I MALFORMATION. 
91. Kjell Å. Salvesen: ROUTINE ULTRASONOGRAPHY IN UTERO AND DEVELOPMENT IN 
CHILDHOOD. 
1994 
92. Nina-Beate Liabakk: DEVELOPMENT OF IMMUNOASSAYS FOR TNF AND ITS SOLUBLE 
RECEPTORS. 
93. Sverre Helge Torp: erbB ONCOGENES IN HUMAN GLIOMAS AND MENINGIOMAS. 
94. Olav M. Linaker: MENTAL RETARDATION AND PSYCHIATRY. Past and present. 
95. Per Oscar Feet: INCREASED ANTIDEPRESSANT AND ANTIPANIC EFFECT IN 
COMBINED TREATMENT WITH DIXYRAZINE AND TRICYCLIC ANTIDEPRESSANTS. 
96. Stein Olav Samstad: CROSS SECTIONAL FLOW VELOCITY PROFILES FROM TWO-
DIMENSIONAL DOPPLER ULTRASOUND: Studies on early mitral blood flow. 
97. Bjørn Backe: STUDIES IN ANTENATAL CARE. 
98. Gerd Inger Ringdal: QUALITY OF LIFE IN CANCER PATIENTS. 
99. Torvid Kiserud: THE DUCTUS VENOSUS IN THE HUMAN FETUS. 
100. Hans E. Fjøsne: HORMONAL REGULATION OF PROSTATIC METABOLISM. 
101. Eylert Brodtkorb: CLINICAL ASPECTS OF EPILEPSY IN THE MENTALLY RETARDED. 
102. Roar Juul: PEPTIDERGIC MECHANISMS IN HUMAN SUBARACHNOID HEMORRHAGE. 
103. Unni Syversen: CHROMOGRANIN A. Phsysiological and Clinical Role. 
1995 
104. Odd Gunnar Brakstad: THERMOSTABLE NUCLEASE AND THE nuc GENE IN THE 
DIAGNOSIS OF Staphylococcus aureus INFECTIONS. 
105. Terje Engan: NUCLEAR MAGNETIC RESONANCE (NMR) SPECTROSCOPY OF PLASMA 
IN MALIGNANT DISEASE. 
106. Kirsten Rasmussen: VIOLENCE IN THE MENTALLY DISORDERED. 
107. Finn Egil Skjeldestad: INDUCED ABORTION: Timetrends and Determinants. 
108. Roar Stenseth: THORACIC EPIDURAL ANALGESIA IN AORTOCORONARY BYPASS 
SURGERY. 
139. Fabio Antonaci: CHRONIC  PAROXYSMAL HEMICRANIA AND HEMICRANIA 
CONTINUA: TWO DIFFERENT ENTITIES? 
140. Sven M. Carlsen: ENDOCRINE AND METABOLIC EFFECTS OF METFORMIN WITH 
SPECIAL EMPHASIS ON CARDIOVASCULAR RISK FACTORES. 
1999 
141. Terje A. Murberg: DEPRESSIVE SYMPTOMS AND COPING AMONG PATIENTS WITH 
CONGESTIVE HEART FAILURE. 
142. Harm-Gerd Karl Blaas: THE EMBRYONIC EXAMINATION. Ultrasound studies on the 
development of the human embryo. 
143. Noèmi Becser Andersen:THE CEPHALIC SENSORY NERVES IN UNILATERAL 
HEADACHES. Anatomical background and neurophysiological evaluation. 
144. Eli-Janne Fiskerstrand: LASER TREATMENT OF PORT WINE STAINS. A study of the efficacy 
and limitations of the pulsed dye laser. Clinical and morfological analyses aimed at improving the 
therapeutic outcome. 
145. Bård Kulseng: A STUDY OF ALGINATE CAPSULE PROPERTIES AND CYTOKINES IN 
RELATION TO INSULIN DEPENDENT DIABETES MELLITUS. 
146. Terje Haug: STRUCTURE AND REGULATION OF THE HUMAN UNG GENE ENCODING 
URACIL-DNA GLYCOSYLASE. 
147. Heidi Brurok: MANGANESE AND THE HEART. A Magic Metal with Diagnostic and 
Therapeutic Possibilites. 
148. Agnes Kathrine Lie: DIAGNOSIS AND PREVALENCE OF HUMAN PAPILLOMAVIRUS 
INFECTION IN CERVICAL INTRAEPITELIAL NEOPLASIA. Relationship to Cell Cycle 
Regulatory Proteins and HLA DQBI Genes. 
149. Ronald Mårvik: PHARMACOLOGICAL, PHYSIOLOGICAL AND PATHOPHYSIOLOGICAL 
STUDIES ON ISOLATED STOMACS. 
150. Ketil Jarl Holen: THE ROLE OF ULTRASONOGRAPHY IN THE DIAGNOSIS AND 
TREATMENT OF HIP DYSPLASIA IN NEWBORNS. 
151. Irene Hetlevik:  THE ROLE OF CLINICAL GUIDELINES IN CARDIOVASCULAR RISK 
INTERVENTION IN GENERAL PRACTICE. 
152. Katarina Tunòn: ULTRASOUND AND PREDICTION OF GESTATIONAL AGE. 
153. Johannes Soma: INTERACTION BETWEEN THE LEFT VENTRICLE AND THE SYSTEMIC 
ARTERIES. 
154. Arild Aamodt: DEVELOPMENT AND PRE-CLINICAL EVALUATION OF A CUSTOM-
MADE FEMORAL STEM. 
155. Agnar Tegnander: DIAGNOSIS AND FOLLOW-UP OF CHILDREN WITH SUSPECTED OR 
KNOWN HIP DYSPLASIA. 
156. Bent Indredavik: STROKE UNIT TREATMENT: SHORT AND LONG-TERM EFFECTS 
157. Jolanta Vanagaite Vingen: PHOTOPHOBIA AND PHONOPHOBIA IN PRIMARY 
HEADACHES 
2000 
158. Ola Dalsegg Sæther: PATHOPHYSIOLOGY DURING PROXIMAL AORTIC CROSS-
CLAMPING CLINICAL AND EXPERIMENTAL STUDIES 
159. xxxxxxxxx (blind number) 
160. Christina Vogt Isaksen: PRENATAL ULTRASOUND AND POSTMORTEM FINDINGS – A 
TEN YEAR CORRELATIVE STUDY OF FETUSES AND INFANTS WITH 
DEVELOPMENTAL ANOMALIES. 
161. Holger Seidel: HIGH-DOSE METHOTREXATE THERAPY IN CHILDREN WITH ACUTE 
LYMPHOCYTIC LEUKEMIA: DOSE, CONCENTRATION, AND EFFECT 
CONSIDERATIONS. 
162. Stein Hallan: IMPLEMENTATION OF MODERN MEDICAL DECISION ANALYSIS INTO 
CLINICAL DIAGNOSIS AND TREATMENT. 
163. Malcolm Sue-Chu: INVASIVE AND NON-INVASIVE STUDIES IN CROSS-COUNTRY 
SKIERS WITH ASTHMA-LIKE SYMPTOMS. 
164. Ole-Lars Brekke: EFFECTS OF ANTIOXIDANTS AND FATTY ACIDS ON TUMOR 
NECROSIS FACTOR-INDUCED CYTOTOXICITY. 
165. Jan Lundbom: AORTOCORONARY BYPASS SURGERY: CLINICAL ASPECTS, COST 
CONSIDERATIONS AND WORKING ABILITY. 
166. John-Anker Zwart: LUMBAR NERVE ROOT COMPRESSION, BIOCHEMICAL AND 
NEUROPHYSIOLOGICAL ASPECTS. 
167. Geir Falck: HYPEROSMOLALITY AND THE HEART. 
168. Eirik Skogvoll: CARDIAC ARREST Incidence, Intervention and Outcome. 
169. Dalius Bansevicius: SHOULDER-NECK REGION IN CERTAIN HEADACHES AND 
CHRONIC PAIN SYNDROMES. 
170. Bettina Kinge: REFRACTIVE ERRORS AND BIOMETRIC CHANGES AMONG 
UNIVERSITY STUDENTS IN NORWAY. 
171. Gunnar Qvigstad: CONSEQUENCES OF HYPERGASTRINEMIA IN MAN 
172. Hanne Ellekjær: EPIDEMIOLOGICAL STUDIES OF STROKE IN A NORWEGIAN 
POPULATION. INCIDENCE, RISK FACTORS AND PROGNOSIS 
173. Hilde Grimstad: VIOLENCE AGAINST WOMEN AND PREGNANCY OUTCOME. 
174. Astrid Hjelde: SURFACE TENSION AND COMPLEMENT ACTIVATION: Factors influencing 
bubble formation and bubble effects after decompression. 
175. Kjell A. Kvistad: MR IN BREAST CANCER – A CLINICAL STUDY. 
176. Ivar Rossvoll: ELECTIVE ORTHOPAEDIC SURGERY IN A DEFINED POPULATION. Studies 
on demand, waiting time for treatment and incapacity for work. 
177. Carina Seidel: PROGNOSTIC VALUE AND BIOLOGICAL EFFECTS OF HEPATOCYTE 
GROWTH FACTOR AND SYNDECAN-1 IN MULTIPLE MYELOMA. 
2001 
178. Alexander Wahba: THE INFLUENCE OF CARDIOPULMONARY BYPASS ON PLATELET 
FUNCTION AND BLOOD COAGULATION – DETERMINANTS AND CLINICAL 
CONSEQUENSES 
179. Marcus Schmitt-Egenolf: THE RELEVANCE OF THE MAJOR hISTOCOMPATIBILITY 
COMPLEX FOR THE GENETICS OF PSORIASIS 
180. Odrun Arna Gederaas: BIOLOGICAL MECHANISMS INVOLVED IN 5-AMINOLEVULINIC 
ACID BASED PHOTODYNAMIC THERAPY 
181. Pål Richard Romundstad: CANCER INCIDENCE AMONG NORWEGIAN ALUMINIUM 
WORKERS 
182. Henrik Hjorth-Hansen: NOVEL CYTOKINES IN GROWTH CONTROL AND BONE DISEASE 
OF MULTIPLE MYELOMA 
183. Gunnar Morken: SEASONAL VARIATION OF HUMAN MOOD AND BEHAVIOUR 
184. Bjørn Olav Haugen: MEASUREMENT OF CARDIAC OUTPUT AND STUDIES OF 
VELOCITY PROFILES IN AORTIC AND MITRAL FLOW USING TWO- AND THREE-
DIMENSIONAL COLOUR FLOW IMAGING 
185. Geir Bråthen: THE CLASSIFICATION AND CLINICAL DIAGNOSIS OF ALCOHOL-
RELATED SEIZURES 
186. Knut Ivar Aasarød: RENAL INVOLVEMENT IN INFLAMMATORY RHEUMATIC DISEASE. 
A Study of Renal Disease in Wegener’s Granulomatosis and in Primary Sjögren’s Syndrome  
187. Trude Helen Flo: RESEPTORS INVOLVED IN CELL ACTIVATION BY DEFINED URONIC 
ACID POLYMERS AND BACTERIAL COMPONENTS 
188. Bodil Kavli: HUMAN URACIL-DNA GLYCOSYLASES FROM THE UNG GENE: 
STRUCTRUAL BASIS FOR SUBSTRATE SPECIFICITY AND REPAIR 
189. Liv Thommesen: MOLECULAR MECHANISMS INVOLVED IN TNF- AND GASTRIN-
MEDIATED GENE REGULATION 
190. Turid Lingaas Holmen: SMOKING AND HEALTH IN ADOLESCENCE; THE NORD-
TRØNDELAG HEALTH STUDY, 1995-97 
191. Øyvind Hjertner: MULTIPLE MYELOMA: INTERACTIONS BETWEEN MALIGNANT 
PLASMA CELLS AND THE BONE MICROENVIRONMENT 
192. Asbjørn Støylen: STRAIN RATE IMAGING OF THE LEFT VENTRICLE BY ULTRASOUND. 
FEASIBILITY, CLINICAL VALIDATION AND PHYSIOLOGICAL ASPECTS 
193. Kristian Midthjell: DIABETES IN ADULTS IN NORD-TRØNDELAG. PUBLIC HEALTH 
ASPECTS OF DIABETES MELLITUS IN A LARGE, NON-SELECTED NORWEGIAN 
POPULATION. 
194. Guanglin Cui: FUNCTIONAL ASPECTS OF THE ECL CELL IN RODENTS 
195. Ulrik Wisløff: CARDIAC EFFECTS OF AEROBIC ENDURANCE TRAINING: 
HYPERTROPHY, CONTRACTILITY AND CALCUIM HANDLING IN NORMAL AND 
FAILING HEART 
196. Øyvind Halaas: MECHANISMS OF IMMUNOMODULATION AND CELL-MEDIATED 
CYTOTOXICITY INDUCED BY BACTERIAL PRODUCTS 
197. Tore Amundsen: PERFUSION MR IMAGING IN THE DIAGNOSIS OF PULMONARY 
EMBOLISM 
198. Nanna Kurtze: THE SIGNIFICANCE OF ANXIETY AND DEPRESSION IN FATIQUE AND 
PATTERNS OF PAIN AMONG INDIVIDUALS DIAGNOSED WITH FIBROMYALGIA: 
RELATIONS WITH QUALITY OF LIFE, FUNCTIONAL DISABILITY, LIFESTYLE, 
EMPLOYMENT STATUS, CO-MORBIDITY AND GENDER 
199. Tom Ivar Lund Nilsen: PROSPECTIVE STUDIES OF CANCER RISK IN NORD-
TRØNDELAG: THE HUNT STUDY. Associations with anthropometric, socioeconomic, and 
lifestyle risk factors 
200. Asta Kristine Håberg: A NEW APPROACH TO THE STUDY OF MIDDLE CEREBRAL 
ARTERY OCCLUSION IN THE RAT USING MAGNETIC RESONANCE TECHNIQUES 
2002 
201. Knut Jørgen Arntzen: PREGNANCY AND CYTOKINES 
202. Henrik Døllner: INFLAMMATORY MEDIATORS IN PERINATAL INFECTIONS 
203. Asta Bye: LOW FAT, LOW LACTOSE DIET USED AS PROPHYLACTIC TREATMENT OF 
ACUTE INTESTINAL REACTIONS DURING PELVIC RADIOTHERAPY. A PROSPECTIVE 
RANDOMISED STUDY. 
204. Sylvester Moyo: STUDIES ON STREPTOCOCCUS AGALACTIAE  (GROUP B 
STREPTOCOCCUS) SURFACE-ANCHORED MARKERS WITH EMPHASIS ON STRAINS 
AND HUMAN SERA FROM ZIMBABWE. 
205. Knut Hagen: HEAD-HUNT: THE EPIDEMIOLOGY OF HEADACHE IN NORD-TRØNDELAG 
206. Li Lixin: ON THE REGULATION AND ROLE OF UNCOUPLING PROTEIN-2 IN INSULIN 
PRODUCING ß-CELLS 
207. Anne Hildur Henriksen: SYMPTOMS OF ALLERGY AND ASTHMA VERSUS MARKERS OF 
LOWER AIRWAY INFLAMMATION AMONG ADOLESCENTS 
208. Egil Andreas Fors: NON-MALIGNANT PAIN IN RELATION TO PSYCHOLOGICAL AND 
ENVIRONTENTAL FACTORS. EXPERIENTAL AND CLINICAL STUDES OF PAIN WITH 
FOCUS ON FIBROMYALGIA 
209. Pål Klepstad:  MORPHINE FOR CANCER PAIN 
210. Ingunn Bakke: MECHANISMS AND CONSEQUENCES OF PEROXISOME PROLIFERATOR-
INDUCED HYPERFUNCTION OF THE RAT GASTRIN PRODUCING CELL 
211. Ingrid Susann Gribbestad: MAGNETIC RESONANCE IMAGING AND SPECTROSCOPY OF 
BREAST CANCER 
212. Rønnaug Astri Ødegård: PREECLAMPSIA – MATERNAL RISK FACTORS AND FETAL 
GROWTH 
213. Johan Haux: STUDIES ON CYTOTOXICITY INDUCED BY HUMAN NATURAL KILLER 
CELLS AND DIGITOXIN 
214. Turid Suzanne Berg-Nielsen: PARENTING PRACTICES AND MENTALLY DISORDERED 
ADOLESCENTS 
215. Astrid Rydning: BLOOD FLOW AS A PROTECTIVE FACTOR FOR THE STOMACH 
MUCOSA. AN EXPERIMENTAL STUDY ON THE ROLE OF MAST CELLS AND SENSORY 
AFFERENT NEURONS 
2003 
216. Jan Pål Loennechen: HEART FAILURE AFTER MYOCARDIAL INFARCTION. Regional 
Differences, Myocyte Function, Gene Expression, and Response to Cariporide, Losartan, and 
Exercise Training. 
217. Elisabeth Qvigstad: EFFECTS OF FATTY ACIDS AND OVER-STIMULATION ON INSULIN 
SECRETION IN MAN 
218. Arne Åsberg: EPIDEMIOLOGICAL STUDIES IN HEREDITARY HEMOCHROMATOSIS: 
PREVALENCE, MORBIDITY AND BENEFIT OF SCREENING. 
219. Johan Fredrik Skomsvoll: REPRODUCTIVE OUTCOME IN WOMEN WITH RHEUMATIC 
DISEASE. A population registry based study of the effects of inflammatory rheumatic disease and 
connective tissue disease on reproductive outcome in Norwegian women in 1967-1995. 
220. Siv Mørkved: URINARY INCONTINENCE DURING PREGNANCY AND AFTER  
DELIVERY: EFFECT OF PELVIC FLOOR MUSCLE TRAINING IN PREVENTION AND 
TREATMENT 
221. Marit S. Jordhøy: THE IMPACT OF COMPREHENSIVE PALLIATIVE CARE 
222. Tom Christian Martinsen: HYPERGASTRINEMIA AND HYPOACIDITY IN RODENTS – 
CAUSES AND CONSEQUENCES  
223. Solveig Tingulstad: CENTRALIZATION OF PRIMARY SURGERY FOR OVARAIN CANCER. 
FEASIBILITY AND IMPACT ON SURVIVAL  
224. Haytham Eloqayli: METABOLIC CHANGES IN THE BRAIN CAUSED BY EPILEPTIC 
SEIZURES 
225. Torunn Bruland: STUDIES OF EARLY RETROVIRUS-HOST INTERACTIONS – VIRAL 
DETERMINANTS FOR PATHOGENESIS AND THE INFLUENCE OF SEX ON THE 
SUSCEPTIBILITY TO FRIEND MURINE LEUKAEMIA VIRUS INFECTION 
226. Torstein Hole: DOPPLER ECHOCARDIOGRAPHIC EVALUATION OF LEFT 
VENTRICULAR FUNCTION IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION 
227. Vibeke Nossum: THE EFFECT OF VASCULAR BUBBLES ON ENDOTHELIAL FUNCTION 
228. Sigurd Fasting: ROUTINE BASED RECORDING OF ADVERSE EVENTS DURING 
ANAESTHESIA – APPLICATION IN QUALITY IMPROVEMENT AND SAFETY 
229. Solfrid Romundstad: EPIDEMIOLOGICAL STUDIES OF MICROALBUMINURIA. THE 
NORD-TRØNDELAG HEALTH STUDY 1995-97 (HUNT 2) 
230. Geir Torheim: PROCESSING OF DYNAMIC DATA SETS IN MAGNETIC RESONANCE 
IMAGING 
231. Catrine Ahlén: SKIN INFECTIONS IN OCCUPATIONAL SATURATION DIVERS IN THE 
NORTH SEA AND THE IMPACT OF THE ENVIRONMENT 
232. Arnulf Langhammer: RESPIRATORY SYMPTOMS, LUNG FUNCTION AND BONE 
MINERAL DENSITY IN A COMPREHENSIVE POPULATION SURVEY. THE NORD-
TRØNDELAG HEALTH STUDY 1995-97. THE BRONCHIAL OBSTRUCTION IN NORD-
TRØNDELAG STUDY 
233. Einar Kjelsås: EATING DISORDERS AND PHYSICAL ACTIVITY IN NON-CLINICAL 
SAMPLES 
234. Arne Wibe: RECTAL CANCER TREATMENT IN NORWAY – STANDARDISATION OF 
SURGERY AND QUALITY ASSURANCE 
2004 
235. Eivind Witsø: BONE GRAFT AS AN ANTIBIOTIC CARRIER 
236. Anne Mari Sund: DEVELOPMENT OF DEPRESSIVE SYMPTOMS IN EARLY 
ADOLESCENCE   
237. Hallvard Lærum: EVALUATION OF ELECTRONIC MEDICAL RECORDS – A CLINICAL 
TASK PERSPECTIVE  
238. Gustav Mikkelsen: ACCESSIBILITY OF INFORMATION IN ELECTRONIC PATIENT 
RECORDS; AN EVALUATION OF THE ROLE OF DATA QUALITY 
239. Steinar Krokstad: SOCIOECONOMIC INEQUALITIES IN HEALTH AND DISABILITY. 
SOCIAL EPIDEMIOLOGY IN THE NORD-TRØNDELAG HEALTH STUDY (HUNT), 
NORWAY 
240. Arne Kristian Myhre: NORMAL VARIATION IN ANOGENITAL ANATOMY AND 
MICROBIOLOGY IN NON-ABUSED PRESCHOOL CHILDREN 
241. Ingunn Dybedal: NEGATIVE REGULATORS OF HEMATOPOIETEC STEM AND 
PROGENITOR CELLS 
242. Beate Sitter: TISSUE CHARACTERIZATION BY HIGH RESOLUTION MAGIC ANGLE 
SPINNING MR SPECTROSCOPY 
243. Per Arne Aas: MACROMOLECULAR MAINTENANCE IN HUMAN CELLS – REPAIR OF 
URACIL IN DNA AND METHYLATIONS IN DNA AND RNA 
244. Anna Bofin:  FINE NEEDLE ASPIRATION CYTOLOGY IN THE PRIMARY 
INVESTIGATION OF BREAST TUMOURS AND IN THE DETERMINATION OF 
TREATMENT STRATEGIES 
245. Jim Aage Nøttestad: DEINSTITUTIONALIZATION AND MENTAL HEALTH CHANGES 
AMONG PEOPLE WITH MENTAL RETARDATION 
246. Reidar Fossmark:  GASTRIC CANCER IN JAPANESE COTTON RATS 
247. Wibeke Nordhøy:  MANGANESE AND THE HEART, INTRACELLULAR MR RELAXATION 
AND WATER EXCHANGE ACROSS THE CARDIAC CELL MEMBRANE 
2005 
248. Sturla Molden:  QUANTITATIVE ANALYSES OF SINGLE UNITS RECORDED FROM THE 
HIPPOCAMPUS AND ENTORHINAL CORTEX OF BEHAVING RATS 
249. Wenche Brenne Drøyvold:  EPIDEMIOLOGICAL STUDIES ON WEIGHT CHANGE AND 
HEALTH IN A LARGE POPULATION.  THE NORD-TRØNDELAG HEALTH STUDY 
(HUNT) 
250. Ragnhild Støen:  ENDOTHELIUM-DEPENDENT VASODILATION IN THE FEMORAL 
ARTERY OF DEVELOPING PIGLETS 
251. Aslak Steinsbekk:  HOMEOPATHY IN THE PREVENTION OF UPPER RESPIRATORY 
TRACT INFECTIONS IN CHILDREN 
252. Hill-Aina Steffenach:  MEMORY IN HIPPOCAMPAL AND CORTICO-HIPPOCAMPAL 
CIRCUITS 
253. Eystein Stordal:  ASPECTS OF THE EPIDEMIOLOGY OF DEPRESSIONS BASED ON SELF-
RATING IN A LARGE GENERAL HEALTH STUDY (THE HUNT-2 STUDY) 
254. Viggo Pettersen:  FROM MUSCLES TO SINGING:  THE ACTIVITY OF ACCESSORY 
BREATHING MUSCLES AND THORAX  MOVEMENT IN CLASSICAL SINGING 
255. Marianne Fyhn:  SPATIAL MAPS IN THE HIPPOCAMPUS AND ENTORHINAL CORTEX 
256. Robert Valderhaug:  OBSESSIVE-COMPULSIVE DISORDER AMONG CHILDREN AND 
ADOLESCENTS:  CHARACTERISTICS AND PSYCHOLOGICAL MANAGEMENT OF 
PATIENTS IN OUTPATIENT PSYCHIATRIC CLINICS 
257. Erik Skaaheim Haug:  INFRARENAL ABDOMINAL  AORTIC ANEURYSMS – 
COMORBIDITY AND RESULTS FOLLOWING OPEN SURGERY 
258. Daniel Kondziella: GLIAL-NEURONAL INTERACTIONS IN EXPERIMENTAL BRAIN 
DISORDERS 
259. Vegard Heimly Brun:  ROUTES TO SPATIAL MEMORY IN HIPPOCAMPAL PLACE CELLS 
260. Kenneth McMillan:  PHYSIOLOGICAL ASSESSMENT AND TRAINING OF ENDURANCE 
AND STRENGTH IN PROFESSIONAL YOUTH SOCCER PLAYERS 
261. Marit Sæbø Indredavik:  MENTAL HEALTH AND CEREBRAL MAGNETIC RESONANCE 
IMAGING IN ADOLESCENTS WITH LOW BIRTH WEIGHT 
262. Ole Johan Kemi:  ON THE CELLULAR BASIS OF AEROBIC FITNESS, INTENSITY-
DEPENDENCE AND TIME-COURSE OF CARDIOMYOCYTE AND ENDOTHELIAL 
ADAPTATIONS TO EXERCISE TRAINING 
263. Eszter Vanky: POLYCYSTIC OVARY SYNDROME – METFORMIN TREATMENT IN 
PREGNANCY 
264. Hild Fjærtoft:  EXTENDED STROKE UNIT SERVICE AND EARLY SUPPORTED 
DISCHARGE.  SHORT AND LONG-TERM EFFECTS   
265. Grete Dyb:  POSTTRAUMATIC STRESS REACTIONS IN CHILDREN AND ADOLESCENTS 
266. Vidar Fykse: SOMATOSTATIN AND THE STOMACH 
267. Kirsti Berg: OXIDATIVE STRESS AND THE ISCHEMIC HEART:  A STUDY IN PATIENTS 
UNDERGOING CORONARY REVASCULARIZATION  
268. Björn Inge Gustafsson:  THE SEROTONIN PRODUCING ENTEROCHROMAFFIN CELL, 
AND EFFECTS OF HYPERSEROTONINEMIA ON HEART AND BONE 
2006 
269. Torstein Baade Rø:  EFFECTS OF BONE MORPHOGENETIC PROTEINS, HEPATOCYTE 
GROWTH FACTOR AND INTERLEUKIN-21 IN MULTIPLE MYELOMA 
270. May-Britt Tessem:  METABOLIC EFFECTS OF ULTRAVIOLET RADIATION ON THE 
ANTERIOR PART OF THE EYE 
271. Anne-Sofie Helvik:  COPING AND EVERYDAY LIFE IN A POPULATION OF ADULTS 
WITH HEARING IMPAIRMENT 
272. Therese Standal:  MULTIPLE MYELOMA:  THE INTERPLAY BETWEEN MALIGNANT 
PLASMA CELLS AND THE BONE MARROW MICROENVIRONMENT 
273. Ingvild Saltvedt:  TREATMENT OF ACUTELY SICK, FRAIL ELDERLY PATIENTS IN A 
GERIATRIC EVALUATION AND MANAGEMENT UNIT – RESULTS FROM A 
PROSPECTIVE RANDOMISED TRIAL 
274. Birger Henning Endreseth:  STRATEGIES IN RECTAL CANCER TREATMENT – FOCUS ON 
EARLY RECTAL CANCER AND THE INFLUENCE OF AGE ON PROGNOSIS 
275. Anne Mari Aukan Rokstad:  ALGINATE CAPSULES AS BIOREACTORS FOR CELL 
THERAPY 
276. Mansour Akbari: HUMAN BASE EXCISION REPAIR FOR PRESERVATION OF GENOMIC 
STABILITY 
277. Stein Sundstrøm:  IMPROVING TREATMENT IN PATIENTS WITH LUNG CANCER – 
RESULTS FROM TWO MULITCENTRE RANDOMISED STUDIES 
278. Hilde Pleym: BLEEDING AFTER CORONARY ARTERY BYPASS SURGERY -  STUDIES 
ON HEMOSTATIC MECHANISMS, PROPHYLACTIC DRUG TREATMENT AND EFFECTS 
OF AUTOTRANSFUSION 
279. Line Merethe Oldervoll:  PHYSICAL ACTIVITY AND EXERCISE INTERVENTIONS IN 
CANCER PATIENTS 
280. Boye Welde:  THE SIGNIFICANCE OF ENDURANCE TRAINING, RESISTANCE TRAINING 
AND MOTIVATIONAL STYLES IN ATHLETIC PERFORMANCE AMONG ELITE JUNIOR 
CROSS-COUNTRY SKIERS 
281. Per Olav Vandvik:  IRRITABLE BOWEL SYNDROME IN NORWAY,  STUDIES OF 
PREVALENCE, DIAGNOSIS AND CHARACTERISTICS IN GENERAL PRACTICE AND IN 
THE POPULATION 
282. Idar Kirkeby-Garstad:  CLINICAL PHYSIOLOGY OF EARLY MOBILIZATION AFTER 
CARDIAC SURGERY 
283. Linn Getz: SUSTAINABLE AND RESPONSIBLE PREVENTIVE MEDICINE.  
CONCEPTUALISING ETHICAL DILEMMAS ARISING FROM CLINICAL 
IMPLEMENTATION OF ADVANCING MEDICAL TECHNOLOGY  
284. Eva Tegnander: DETECTION OF CONGENITAL HEART DEFECTS  IN A NON-SELECTED 
POPULATION OF 42,381 FETUSES 
285. Kristin Gabestad Nørsett:  GENE EXPRESSION STUDIES IN GASTROINTESTINAL 
PATHOPHYSIOLOGY AND NEOPLASIA 
286. Per Magnus Haram:  GENETIC VS. AQUIRED FITNESS:  METABOLIC, VASCULAR AND 
CARDIOMYOCYTE  ADAPTATIONS 
287. Agneta Johansson:  GENERAL RISK FACTORS FOR GAMBLING PROBLEMS AND THE 
PREVALENCE OG PATHOLOGICAL GAMBLING IN NORWAY  
288. Svein Artur Jensen:  THE PREVALENCE OF SYMPTOMATIC ARTERIAL DISEASE OF THE 
LOWER LIMB 
289. Charlotte Björk Ingul:  QUANITIFICATION OF REGIONAL MYOCARDIAL FUNCTION BY 
STRAIN RATE AND STRAIN FOR EVALUATION OF CORONARY ARTERY DISEASE.  
AUTOMATED VERSUS MANUAL ANALYSIS DURING ACUTE MYOCARDIAL 
INFARCTION AND DOBUTAMINE STRESS ECHOCARDIOGRAPHY 
290. Jakob Nakling:  RESULTS AND CONSEQUENCES OF ROUTINE ULTRASOUND 
SCREENING IN PREGNANCY – A GEOGRAPHIC BASED POPULATION STUDY 
291. Anne Engum:  DEPRESSION AND ANXIETY – THEIR RELATIONS TO THYROID 
DYSFUNCTION AND DIABETES IN A LARGE EPIDEMIOLOGICAL STUDY 
292. Ottar Bjerkeset: ANXIETY AND DEPRESSION IN THE GENERAL POPULATION:  RISK 
FACTORS, INTERVENTION AND OUTCOME – THE NORD-TRØNDELAG HEALTH 
STUDY (HUNT) 
293. Jon Olav Drogset:  RESULTS AFTER SURGICAL TREATMENT OF ANTERIOR CRUCIATE 
LIGAMENT INJURIES – A CLINICAL STUDY  
294. Lars Fosse: MECHANICAL BEHAVIOUR OF COMPACTED MORSELLISED BONE – AN 
EXPERIMENTAL IN VITRO STUDY 
295. Gunilla Klensmeden Fosse: MENTAL HEALTH OF PSYCHIATRIC OUTPATIENTS BULLIED 
IN CHILDHOOD 
296. Paul Jarle Mork:  MUSCLE ACTIVITY IN WORK  AND LEISURE AND ITS ASSOCIATION 
TO MUSCULOSKELETAL PAIN 
297. Björn Stenström:  LESSONS FROM RODENTS:  I: MECHANISMS OF OBESITY SURGERY – 
ROLE OF STOMACH.  II: CARCINOGENIC EFFECTS OF HELICOBACTER PYLORI AND 
SNUS IN THE STOMACH 
298. Haakon R. Skogseth:  INVASIVE PROPERTIES OF CANCER – A TREATMENT TARGET ?  
IN VITRO STUDIES IN HUMAN PROSTATE CANCER CELL LINES 
299. Janniche Hammer:  GLUTAMATE METABOLISM AND CYCLING IN MESIAL TEMPORAL 
LOBE EPILEPSY 
300. May Britt Drugli:  YOUNG CHILDREN TREATED BECAUSE OF ODD/CD:  CONDUCT 
PROBLEMS AND SOCIAL COMPETENCIES IN DAY-CARE AND SCHOOL SETTINGS 
301. Arne Skjold:  MAGNETIC RESONANCE KINETICS OF MANGANESE DIPYRIDOXYL 
DIPHOSPHATE (MnDPDP) IN HUMAN MYOCARDIUM.  STUDIES IN HEALTHY 
VOLUNTEERS AND IN PATIENTS WITH RECENT MYOCARDIAL INFARCTION 
302. Siri Malm:  LEFT VENTRICULAR SYSTOLIC FUNCTION AND MYOCARDIAL 
PERFUSION ASSESSED BY CONTRAST ECHOCARDIOGRAPHY 
303. Valentina Maria do Rosario Cabral Iversen:  MENTAL HEALTH AND PSYCHOLOGICAL 
ADAPTATION OF CLINICAL AND NON-CLINICAL MIGRANT GROUPS 
304. Lasse Løvstakken:  SIGNAL PROCESSING IN DIAGNOSTIC ULTRASOUND:  
ALGORITHMS FOR REAL-TIME ESTIMATION AND VISUALIZATION OF BLOOD FLOW 
VELOCITY 
305. Elisabeth Olstad:  GLUTAMATE AND GABA:  MAJOR PLAYERS IN NEURONAL 
METABOLISM  
306. Lilian Leistad:  THE ROLE OF CYTOKINES AND PHOSPHOLIPASE A2s  IN ARTICULAR 
CARTILAGE CHONDROCYTES IN RHEUMATOID ARTHRITIS AND OSTEOARTHRITIS 
307. Arne Vaaler:  EFFECTS OF PSYCHIATRIC INTENSIVE CARE UNIT IN AN ACUTE 
PSYCIATHRIC WARD 
 
